8-K · 2026-11-12
BioRestorative Therapies, Inc. announces board changes with two resignations and a new director appointment, signaling potential strategic shifts.
| Name | BioRestorative Therapies, Inc. |
|---|---|
| CIK | 0001505497 |
| Tickers | BRTX |
| Exchanges | Nasdaq |
| Entity type | operating |
| Category | Non-accelerated filer<br>Smaller reporting company |
| SIC | 8090 Services-Misc Health & Allied Services, NEC |
| EIN | 301341024 |
| LEI | — |
| Fiscal year end | 1231 |
| State of incorporation | NV NV |
| Phone | (631) 760-8100 |
| Website | — |
| Investor website | — |
| Owner org | 08 Industrial Applications and Services |
| Flags | — |
| Description | — |
| Insider transactions (issuer) | 1 |
| Insider transactions (owner) | 0 |
EDGAR has no company-logo API. Website field is shown when the filer provided one.
BioRestorative Therapies, Inc. announces board changes with two resignations and a new director appointment, signaling potential strategic shifts.
756 filing rows loaded from submissions recent.
| Filed | Form | Document | Items | Accession | File no. | Film | Act | Size | XBRL | iXBRL |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-16 | NT 10-Q | NOTIFICATION OF LATE FILING | 0001213900-26-120589 | 001-37603 | 261560257 | 34 | 25219 | |||
| 2026-11-12 | 8-K | CURRENT REPORT | 5.02,9.01 | 0001213900-26-119019 | 001-37603 | 261547910 | 34 | 196593 | 1 | 1 |
| 2026-10-09 | 8-K | CURRENT REPORT | 5.02,9.01 | 0001213900-26-108467 | 001-37603 | 261452947 | 34 | 198696 | 1 | 1 |
| 2026-09-11 | 8-K | CURRENT REPORT | 5.02,9.01 | 0001213900-26-099018 | 001-37603 | 261372874 | 34 | 193171 | 1 | 1 |
| 2026-09-10 | 8-K/A | AMENDMENT NO. 1 TO FORM 8-K | 4.01,8.01,9.01 | 0001213900-26-098820 | 001-37603 | 261371484 | 34 | 215360 | 1 | 1 |
| 2026-09-02 | 8-K | CURRENT REPORT | 3.03,5.03,7.01,9.01 | 0001213900-26-096810 | 001-37603 | 261356065 | 34 | 235542 | 1 | 1 |
| 2026-09-02 | 8-K | CURRENT REPORT | 4.01,5.02,9.01 | 0001213900-26-096337 | 001-37603 | 261352055 | 34 | 482915 | 1 | 1 |
| 2026-08-25 | 8-K | CURRENT REPORT | 3.01,9.01 | 0001213900-26-093566 | 001-37603 | 261316678 | 34 | 193962 | 1 | 1 |
| 2026-08-14 | NT 10-Q | NT 10-Q | 0001493152-26-038425 | 001-37603 | 261282294 | 34 | 35251 | |||
| 2026-08-14 | 8-K | 8-K | 8.01,9.01 | 0001493152-26-038391 | 001-37603 | 261281933 | 34 | 201708 | 1 | 1 |
| 2026-08-03 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001094891-26-000263 | 005-86699 | 261233145 | 34 | 6827 | |||
| 2026-07-30 | 3 | xslF345X06/ownership.xml | 0001213900-26-083461 | 3220 | ||||||
| 2026-07-24 | 3 | PRIMARY DOCUMENT | 0002146283-26-000001 | 3021 | ||||||
| 2026-07-16 | 8-K | 8-K | 5.02,9.01 | 0001493152-26-033593 | 001-37603 | 261181333 | 34 | 1484483 | 1 | 1 |
| 2026-06-18 | 3 | xslF345X06/ownership.xml | 0001213900-26-070160 | 3164 | ||||||
| 2026-06-18 | 3 | xslF345X06/ownership.xml | 0001213900-26-069973 | 3203 | ||||||
| 2026-06-17 | 3 | xslF345X06/ownership.xml | 0001213900-26-069704 | 3189 | ||||||
| 2026-06-12 | 8-K | CURRENT REPORT FILING | 5.02,9.01 | 0001021771-26-000093 | 001-37603 | 261087737 | 34 | 249967 | 1 | 1 |
| 2026-06-12 | 8-K | CURRENT REPORT FILING | 1.01,5.02,9.01 | 0001021771-26-000091 | 001-37603 | 261087683 | 34 | 345460 | 1 | 1 |
| 2026-05-29 | 8-K | FORM 8-K DATED MARCH 26, 2026 | 5.02,5.07,9.01 | 0001021771-26-000084 | 001-37603 | 261045884 | 34 | 1025738 | 1 | 1 |
| 2026-05-15 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001700205-26-000004 | 005-86699 | 26986233 | 34 | 81080 | |||
| 2026-05-14 | 10-Q | 10-Q | 0001493152-26-023126 | 001-37603 | 26979627 | 34 | 4553343 | 1 | 1 | |
| 2026-05-01 | 8-K | CURRENT REPORT FILING | 5.02 | 0001021771-26-000068 | 001-37603 | 26932810 | 34 | 235196 | 1 | 1 |
| 2026-04-30 | 424B3 | 424B3 | 0001493152-26-020495 | 333-293322 | 26925366 | 33 | 208293 | |||
| 2026-04-28 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-26-001353 | 333-293322 | 26910252 | 33 | 1869 | ||
| 2026-04-27 | POS AM | POS AM | 0001493152-26-019129 | 333-293322 | 26900858 | 33 | 244739 | |||
| 2026-04-23 | 8-K | CURRENT REPORT FILING | 7.01,9.01 | 0001021771-26-000058 | 001-37603 | 26889697 | 34 | 10359985 | 1 | 1 |
| 2026-04-20 | POS AM | POS AM | 0001493152-26-018143 | 333-293322 | 26876143 | 33 | 586621 | 1 | 1 | |
| 2026-04-13 | DEF 14A | def14a.htm | 0001021771-26-000042 | 001-37603 | 26858573 | 34 | 2779636 | |||
| 2026-04-03 | PRE 14A | PRELIMINARY PROXY STATEMENT NOT RELATED TO A CONTESTED MATTER OR MERGER/ACQUISIT | 0001021771-26-000039 | 001-37603 | 26837742 | 34 | 109809 | |||
| 2026-03-26 | 10-K | 10-K | 0001493152-26-012925 | 001-37603 | 26798548 | 34 | 10551128 | 1 | 1 | |
| 2026-02-23 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0002027680-26-000001 | 005-86699 | 26666025 | 34 | 6501 | |||
| 2026-02-18 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001213900-26-017939 | 005-86699 | 26648405 | 34 | 16929 | |||
| 2026-02-17 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001700205-26-000003 | 005-86699 | 26639614 | 34 | 81161 | |||
| 2026-02-17 | 8-K | 8-K | 1.01,7.01,9.01 | 0001493152-26-006837 | 001-37603 | 26635684 | 34 | 362215 | 1 | 1 |
| 2026-02-13 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001896206-26-000003 | 005-86699 | 26633184 | 34 | 7066 | |||
| 2026-02-13 | 424B4 | 424B4 | 0001493152-26-006580 | 333-293322 | 26629401 | 33 | 2576430 | |||
| 2026-02-11 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-26-000543 | 333-293322 | 26623107 | 33 | 1856 | ||
| 2026-02-10 | CORRESP | filename1.htm | 0001021771-26-000020 | 9625 | ||||||
| 2026-02-10 | S-1/A | S-1/A | 0001493152-26-006012 | 333-293322 | 26617313 | 33 | 429769 | 1 | 1 | |
| 2026-02-09 | S-1 | S-1 | 0001493152-26-005827 | 333-293322 | 26612635 | 33 | 12609437 | 1 | 1 | |
| 2025-12-19 | DRS | filename1.htm | 0001493152-25-028561 | 377-08843 | 251587714 | 33 | 461683 | |||
| 2025-12-19 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0002027680-25-000006 | 005-86699 | 251587126 | 34 | 6701 | |||
| 2025-12-12 | 424B3 | PROSPECTUS RE 508,592 SHARES OF COMMON STOCK | 0001021771-25-000152 | 333-291623 | 251569073 | 33 | 167990 | |||
| 2025-12-10 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-25-003635 | 333-291623 | 251563423 | 33 | 1857 | ||
| 2025-12-08 | CORRESP | filename1.htm | 0001021771-25-000150 | 8108 | ||||||
| 2025-11-18 | S-8 | S-8 | 0001493152-25-024082 | 333-291624 | 251495472 | 33 | 241525 | 1 | 1 | |
| 2025-11-18 | S-1 | S-1 | 0001493152-25-024081 | 333-291623 | 251495424 | 33 | 588157 | 1 | 1 | |
| 2025-11-12 | 10-Q | 10-Q | 0001493152-25-021993 | 001-37603 | 251474001 | 34 | 4395435 | 1 | 1 | |
| 2025-11-12 | 8-K | THIRD QUARTER 2025 FINANCIAL RESULTS | 2.02,7.01,9.01 | 0001021771-25-000148 | 001-37603 | 251472842 | 34 | 4737870 | 1 | 1 |
| 2025-10-20 | 4 | xslF345X05/form4.xml | 0001021771-25-000141 | 17736 | ||||||
| 2025-10-20 | 4 | xslF345X05/form4.xml | 0001021771-25-000140 | 13447 | ||||||
| 2025-10-09 | D | xslFormDX01/primary_doc.xml | 06b | 0001021771-25-000134 | 021-560305 | 251384234 | 33 | 11225 | ||
| 2025-10-08 | 8-K | 8-K | 1.01,3.02,7.01,9.01 | 0001493152-25-017446 | 001-37603 | 251383077 | 34 | 648924 | 1 | 1 |
| 2025-10-08 | 424B5 | 424B5 | 0001493152-25-017433 | 333-269631 | 251382597 | 33 | 419719 | |||
| 2025-10-06 | 424B5 | 424B5 | 0001493152-25-017037 | 333-269631 | 251376126 | 33 | 18807 | |||
| 2025-09-25 | 8-K | ANNUAL MEETING VOTE | 5.07 | 0001021771-25-000131 | 001-37603 | 251341309 | 34 | 163405 | 1 | 1 |
| 2025-08-14 | 8-K | PRESENTATION MATERIALS | 7.01,9.01 | 0001021771-25-000116 | 001-37603 | 251220864 | 34 | 16266209 | 1 | 1 |
| 2025-08-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001604867-25-000015 | 005-86699 | 251217928 | 34 | 81142 | |||
| 2025-08-12 | 10-Q | 10-Q | 0001641172-25-023211 | 001-37603 | 251207234 | 34 | 4046054 | 1 | 1 | |
| 2025-08-12 | 8-K | Q2 2025 EARNINGS, BUSINESS UPDATE AND CONFERENCE CALL | 2.02,7.01,9.01 | 0001021771-25-000113 | 001-37603 | 251206944 | 34 | 4461569 | 1 | 1 |
| 2025-08-08 | DEF 14A | DEF 14A | 0001641172-25-022812 | 001-37603 | 251199366 | 34 | 4630914 | 1 | 1 | |
| 2025-06-13 | 8-K | PRESENTATION - INTERNATIONAL SOCIETY FOR STEM CELL RESEARCH | 7.01,9.01 | 0001021771-25-000092 | 001-37603 | 251044812 | 34 | 16513118 | 1 | 1 |
| 2025-05-15 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001700205-25-000001 | 005-86699 | 25950203 | 34 | 80948 | |||
| 2025-05-14 | 10-Q | 10-Q | 0001641172-25-010299 | 001-37603 | 25946241 | 34 | 3649914 | 1 | 1 | |
| 2025-05-14 | 8-K | FIRST QUARTER 2025 AND BUSINESS UPDATE CONFERENCE CALL | 2.02,7.01,9.01 | 0001021771-25-000079 | 001-37603 | 25945599 | 34 | 4712054 | 1 | 1 |
| 2025-04-21 | 8-K | CHANGE IN ACCOUNTANTS | 4.01,9.01 | 0001021771-25-000074 | 001-37603 | 25853211 | 34 | 168642 | 1 | 1 |
| 2025-03-28 | 10-K | form10-k.htm | 0001641172-25-001011 | 001-37603 | 25781182 | 34 | 10455398 | 1 | 1 | |
| 2025-03-27 | 8-K | FINANCIAL RESULTS YEAR ENDED DECEMBER 31, 2024 AND CONFERENCE CALL | 2.02,7.01,9.01 | 0001021771-25-000066 | 001-37603 | 25779380 | 34 | 2843914 | 1 | 1 |
| 2025-02-28 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0002027680-25-000003 | 005-86699 | 25682754 | 34 | 6107 | |||
| 2025-02-19 | SCHEDULE 13D/A | xslSCHEDULE_13D_X01/primary_doc.xml | 0001021771-25-000050 | 005-86699 | 25641088 | 34 | 46347 | |||
| 2025-02-19 | SCHEDULE 13D/A | xslSCHEDULE_13D_X01/primary_doc.xml | 0001021771-25-000048 | 005-86699 | 25641009 | 34 | 59344 | |||
| 2025-02-19 | 4 | xslF345X05/form4.xml | 0001021771-25-000046 | 8782 | ||||||
| 2025-02-19 | 4 | xslF345X05/form4.xml | 0001021771-25-000044 | 8824 | ||||||
| 2025-02-19 | 4 | xslF345X05/form4.xml | 0001021771-25-000042 | 8769 | ||||||
| 2025-02-19 | 4 | xslF345X05/form4.xml | 0001021771-25-000040 | 10172 | ||||||
| 2025-02-19 | 4 | xslF345X05/form4.xml | 0001021771-25-000038 | 16830 | ||||||
| 2025-02-19 | 4 | xslF345X05/form4.xml | 0001021771-25-000036 | 11373 | ||||||
| 2025-02-19 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0002027680-25-000002 | 005-86699 | 25637205 | 34 | 6114 | |||
| 2025-02-10 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0002027680-25-000001 | 005-86699 | 25606093 | 34 | 6113 | |||
| 2025-02-10 | 8-K | ORS PRESENTATION | 7.01,9.01 | 0001021771-25-000031 | 001-37603 | 25603757 | 34 | 20329149 | 1 | 1 |
| 2024-12-05 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0002027680-24-000004 | 005-86699 | 241530075 | 34 | 6093 | |||
| 2024-11-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001700205-24-000004 | 005-86699 | 241459452 | 34 | 80964 | |||
| 2024-11-13 | 8-K | THIRD QUARTER RESULTS AND ORS PRESENTATION | 2.02,7.01,9.01 | 0001021771-24-000195 | 001-37603 | 241454167 | 34 | 15303306 | 1 | 1 |
| 2024-11-13 | S-8 | s8111324.htm | 0001021771-24-000194 | 333-283197 | 241454086 | 33 | 64979 | |||
| 2024-11-12 | 10-Q | form10-q.htm | 0001493152-24-044763 | 001-37603 | 241448395 | 34 | 4764187 | 1 | 1 | |
| 2024-11-07 | 8-K | ADDITIONAL PRELIMINARY PHASE 2 DATA AND REVIEW OF THIRD QUARTER CONFERENCE CALL | 7.01,9.01 | 0001021771-24-000190 | 001-37603 | 241432463 | 34 | 3712586 | 1 | 1 |
| 2024-11-06 | 8-K | RODMAN & RENSHAW AT THE MARKET OFFERING AGREEMENT | 1.01,1.02,9.01 | 0001021771-24-000188 | 001-37603 | 241431746 | 34 | 550679 | 1 | 1 |
| 2024-11-06 | 424B5 | PROSPECTUS SUPPLEMENT TO PROSPECTUS DATED FEBRUARY 14, 2023 | 0001021771-24-000186 | 333-269631 | 241431664 | 33 | 297416 | |||
| 2024-11-06 | 10-K/A | form10-ka.htm | 0001493152-24-043839 | 001-37603 | 241431430 | 34 | 413299 | 1 | 1 | |
| 2024-11-05 | 4 | xslF345X05/form4.xml | 0001021771-24-000184 | 5063 | ||||||
| 2024-09-23 | 8-K | SHAREHOLDER VOTE | 5.07 | 0001021771-24-000180 | 001-37603 | 241316597 | 34 | 165569 | 1 | 1 |
| 2024-08-13 | 10-Q | form10-q.htm | 0001493152-24-031636 | 001-37603 | 241202177 | 34 | 4354017 | 1 | 1 | |
| 2024-08-13 | 8-K | SECOND QUARTER RESULTS | 2.02,7.01,9.01 | 0001021771-24-000166 | 001-37603 | 241201540 | 34 | 4498345 | 1 | 1 |
| 2024-08-08 | DEF 14A | ANNUAL MEETING PROXY STATEMENT | 0001021771-24-000160 | 001-37603 | 241188792 | 34 | 1962538 | |||
| 2024-08-06 | 8-K | PRESS RELEASE RE SECOND QUARTER RESULTS AND CONFERENCE CALL | 2.02,7.01,9.01 | 0001021771-24-000158 | 001-37603 | 241180115 | 34 | 2485340 | 1 | 1 |
| 2024-06-21 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0002027680-24-000002 | 005-86699 | 241061678 | 34 | 6558 | |||
| 2024-06-11 | 10-Q | form10-q.htm | 0001493152-24-023481 | 001-37603 | 241036170 | 34 | 3968355 | 1 | 1 | |
| 2024-06-11 | 10-K/A | form10-ka.htm | 0001493152-24-023479 | 001-37603 | 241036108 | 34 | 11384701 | 1 | 1 | |
| 2024-05-24 | 8-K | RE DELISTING | 3.01 | 0001021771-24-000142 | 001-37603 | 24985225 | 34 | 156871 | 1 | 1 |
| 2024-05-24 | 8-K | RE: RESTATEMENT | 4.02 | 0001021771-24-000140 | 001-37603 | 24985158 | 34 | 162937 | 1 | 1 |
| 2024-05-16 | NT 10-Q | MARCH 31, 2024 | 0001021771-24-000130 | 001-37603 | 24956779 | 34 | 25484 | |||
| 2024-04-19 | 424B3 | 2,513,686 SHARES OF COMMON STOCK | 0001021771-24-000111 | 333-278488 | 24858318 | 33 | 190651 | |||
| 2024-04-18 | EFFECT | xslEFFECTX01/primary_doc.xml | S-1,,2024-04-18 17:00:00 | 9999999995-24-001030 | 333-278488 | 24855498 | 33 | 1832 | ||
| 2024-04-17 | CORRESP | filename1.htm | 0001021771-24-000103 | 6948 | ||||||
| 2024-04-12 | S-1/A | AMENDMENT NO. 1 | 0001021771-24-000099 | 333-278488 | 24842149 | 33 | 97540 | |||
| 2024-04-11 | UPLOAD | filename1.pdf | 0000000000-24-003948 | 333-278488 | 40489 | |||||
| 2024-04-10 | 4 | xslF345X05/form4.xml | 0001021771-24-000091 | 19542 | ||||||
| 2024-04-03 | S-1 | S-1 | 0001021771-24-000084 | 333-278488 | 24818985 | 33 | 374981 | |||
| 2024-04-01 | 10-K | form10-k.htm | 0001493152-24-012056 | 001-37603 | 24805054 | 34 | 9417866 | 1 | 1 | |
| 2024-03-20 | 4 | xslF345X05/form4.xml | 0001021771-24-000079 | 16978 | ||||||
| 2024-03-20 | 4 | xslF345X05/form4.xml | 0001021771-24-000077 | 10328 | ||||||
| 2024-03-12 | 8-K | RE PRESENTATION MATERIALS | 7.01,9.01 | 0001021771-24-000068 | 001-37603 | 24740189 | 34 | 22003251 | 1 | 1 |
| 2024-03-06 | SC 13D/A | SCHEDULE 13D AMENDMENT 9 | 0001021771-24-000065 | 005-86699 | 24726442 | 34 | 61406 | |||
| 2024-02-15 | SC 13D/A | SCHEDULE 13D/AMENDMENT 2 | 0001021771-24-000060 | 005-86699 | 24644452 | 34 | 86804 | |||
| 2024-02-15 | SC 13D/A | SCHEDULE 13D AMENDMENT 2 | 0001021771-24-000058 | 005-86699 | 24644410 | 34 | 86433 | |||
| 2024-02-15 | 4 | xslF345X05/form4.xml | 0001021771-24-000056 | 7795 | ||||||
| 2024-02-15 | 4 | xslF345X05/form4.xml | 0001021771-24-000054 | 7837 | ||||||
| 2024-02-15 | 4 | xslF345X05/form4.xml | 0001021771-24-000052 | 8067 | ||||||
| 2024-02-15 | 4 | xslF345X05/form4.xml | 0001021771-24-000050 | 8091 | ||||||
| 2024-02-15 | 4 | xslF345X05/form4.xml | 0001021771-24-000048 | 8657 | ||||||
| 2024-02-15 | 4 | xslF345X05/form4.xml | 0001021771-24-000046 | 19428 | ||||||
| 2024-02-15 | 4 | xslF345X05/form4.xml | 0001021771-24-000044 | 10422 | ||||||
| 2024-02-14 | SC 13G/A | brtx_13gv2.htm | 0001700205-24-000002 | 005-86699 | 24635671 | 34 | 110562 | |||
| 2024-02-12 | 4 | xslF345X05/form4.xml | 0001021771-24-000038 | 10325 | ||||||
| 2024-02-09 | 4 | xslF345X05/form4.xml | 0001021771-24-000035 | 10161 | ||||||
| 2024-02-08 | 8-K | FORM 8-K DATED FEBRUARY 6, 2024 | 1.01,3.02,8.01,9.01 | 0001021771-24-000033 | 001-37603 | 24609150 | 34 | 548419 | 1 | 1 |
| 2024-02-05 | 8-K | RE AUTOLOGOUS STEM CELL THERAPY POSTER | 7.01,9.01 | 0001021771-24-000027 | 001-37603 | 24593988 | 34 | 2060866 | 1 | 1 |
| 2024-02-01 | 8-K | PRESS RELEASE RE PRELIMINARY PHASE 2 CLINICAL TRIAL | 7.01,9.01 | 0001021771-24-000025 | 001-37603 | 24587575 | 34 | 2451541 | 1 | 1 |
| 2023-12-05 | 4 | xslF345X05/form4.xml | 0001021771-23-000118 | 8692 | ||||||
| 2023-12-01 | 4 | xslF345X05/form4.xml | 0001021771-23-000116 | 8691 | ||||||
| 2023-11-15 | S-8 | REGISTRATION OF ADDITIONAL 1,350,000 UNDER 2021 STOCK INCENTIVE PLAN | 0001021771-23-000112 | 333-275571 | 231410730 | 33 | 66326 | |||
| 2023-11-13 | 10-Q | form10-q.htm | 0001493152-23-040483 | 001-37603 | 231398620 | 34 | 3837207 | 1 | 1 | |
| 2023-09-18 | 4 | xslF345X05/form4.xml | 0001021771-23-000098 | 10057 | ||||||
| 2023-09-18 | 4 | xslF345X05/form4.xml | 0001021771-23-000096 | 9578 | ||||||
| 2023-09-15 | 8-K | SHAREHOLDER VOTE | 5.07 | 0001021771-23-000094 | 001-37603 | 231259037 | 34 | 176718 | 1 | 1 |
| 2023-09-14 | 4 | xslF345X05/form4.xml | 0001021771-23-000092 | 10848 | ||||||
| 2023-09-13 | 4 | xslF345X05/form4.xml | 0001021771-23-000090 | 9580 | ||||||
| 2023-09-06 | 4 | xslF345X05/form4.xml | 0001021771-23-000088 | 9579 | ||||||
| 2023-08-31 | 4 | xslF345X05/form4.xml | 0001021771-23-000086 | 19410 | ||||||
| 2023-08-23 | 424B5 | SUPPLEMENT NO. 3 TO PROSPECTUS SUPPLEMENT DATED APRIL 14, 2023 | 0001021771-23-000072 | 333-269631 | 231198248 | 33 | 15606 | |||
| 2023-08-11 | 10-Q | form10-q.htm | 0001493152-23-027825 | 001-37603 | 231164024 | 34 | 5943643 | 1 | 1 | |
| 2023-08-04 | DEF 14A | 2023 ANNUAL MEETING PROXY STATEMENT | 0001021771-23-000063 | 001-37603 | 231143961 | 34 | 1887983 | |||
| 2023-07-28 | 4 | xslF345X05/form4.xml | 0001140361-23-036665 | 8534 | ||||||
| 2023-07-25 | 4 | xslF345X05/form4.xml | 0001140361-23-036103 | 9540 | ||||||
| 2023-07-13 | 8-K | FORM 8-K DATED JULY 11, 2023 | 1.01,8.01,9.01 | 0001021771-23-000057 | 001-37603 | 231085481 | 34 | 494127 | 1 | 1 |
| 2023-07-13 | 424B5 | form424b5.htm | 0001493152-23-024361 | 333-269631 | 231085455 | 33 | 375605 | |||
| 2023-07-11 | 424B5 | SUPPLEMENT NO. 2 | 0001021771-23-000054 | 333-269631 | 231081222 | 33 | 12633 | |||
| 2023-05-15 | 424B5 | SUPPLEMENT NO. 1 TO PROSPECTUS SUPPLEMENT DATED APRIL 14, 2023 | 0001021771-23-000043 | 333-269631 | 23924357 | 33 | 15844 | |||
| 2023-05-12 | 10-Q | form10-q.htm | 0001493152-23-016630 | 001-37603 | 23915593 | 34 | 3288088 | 1 | 1 | |
| 2023-04-14 | 8-K | form8-k.htm | 1.01,9.01 | 0001493152-23-012377 | 001-37603 | 23822104 | 34 | 651140 | 1 | 1 |
| 2023-04-14 | 424B2 | form424b2.htm | 0001493152-23-012371 | 333-269631 | 23822040 | 33 | 381642 | |||
| 2023-04-06 | 8-K | RE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM'S CONSENT | 8.01,9.01 | 0001021771-23-000037 | 001-37603 | 23806492 | 34 | 983478 | 1 | 1 |
| 2023-04-04 | 4 | xslF345X04/form4.xml | 0001021771-23-000034 | 19375 | ||||||
| 2023-03-28 | S-8 | FORM S-8 DATED MARCH 28, 2023 | 0001021771-23-000030 | 333-270909 | 23770495 | 33 | 65486 | |||
| 2023-03-27 | 10-K | form10-k.htm | 0001493152-23-008960 | 001-37603 | 23761130 | 34 | 7827102 | 1 | 1 | |
| 2023-03-22 | 4 | xslF345X04/form4.xml | 0001021771-23-000028 | 19543 | ||||||
| 2023-03-22 | 4 | xslF345X04/form4.xml | 0001021771-23-000026 | 9230 | ||||||
| 2023-03-03 | 4 | FORM 4 | 0001567619-23-004348 | 15657 | ||||||
| 2023-02-28 | 4 | FORM 4 | 0001567619-23-003891 | 19760 | ||||||
| 2023-02-27 | 4 | FORM 4 | 0001567619-23-003875 | 9488 | ||||||
| 2023-02-17 | 4 | FORM 4 | 0001567619-23-003365 | 6903 | ||||||
| 2023-02-17 | 4 | FORM 4 | 0001567619-23-003334 | 6779 | ||||||
| 2023-02-17 | 4 | FORM 4 | 0001567619-23-003332 | 6820 | ||||||
| 2023-02-17 | 4 | FORM 4 | 0001567619-23-003330 | 6850 | ||||||
| 2023-02-17 | 4 | FORM 4 | 0001567619-23-003328 | 7460 | ||||||
| 2023-02-17 | 4 | FORM 4 | 0001567619-23-003326 | 19634 | ||||||
| 2023-02-17 | 4 | FORM 4 | 0001567619-23-003324 | 9362 | ||||||
| 2023-02-17 | SC 13D/A | AMENDMENT 1 | 0001021771-23-000022 | 005-86699 | 23644131 | 34 | 109723 | |||
| 2023-02-17 | SC 13D/A | AMENDMENT 1 | 0001021771-23-000021 | 005-86699 | 23644118 | 34 | 130264 | |||
| 2023-02-14 | EFFECT | xslEFFECTX01/primary_doc.xml | S-3,,2023-02-14 17:00:00 | 9999999995-23-000435 | 333-269631 | 23633484 | 33 | 1791 | ||
| 2023-02-14 | SC 13G/A | BRTX_13g_22_v5.htm | 0001700205-23-000003 | 005-86699 | 23626067 | 34 | 110457 | |||
| 2023-02-13 | CORRESP | filename1.htm | 0001021771-23-000014 | 7228 | ||||||
| 2023-02-13 | S-3/A | AMENDMENT 1 | 0001021771-23-000012 | 333-269631 | 23615252 | 33 | 485754 | |||
| 2023-02-10 | UPLOAD | filename1.pdf | 0000000000-23-001435 | 40377 | ||||||
| 2023-02-07 | S-3 | COMMON STOCK, PREFERRED STOCK, WARRANTS, DEBT SECURITIES AND UNITS | 0001021771-23-000010 | 333-269631 | 23596409 | 33 | 317575 | |||
| 2023-02-07 | SC 13G/A | BRTX 13GA | 0001393825-23-000061 | 005-86699 | 23595653 | 34 | 57118 | |||
| 2023-02-02 | 4 | FORM 4 | 0001567619-23-001697 | 8328 | ||||||
| 2023-01-30 | 4 | FORM 4 | 0001567619-23-001399 | 7847 | ||||||
| 2023-01-24 | 4 | FORM 4 | 0001567619-23-001186 | 9307 | ||||||
| 2023-01-20 | 4 | FORM 4 | 0001567619-23-001056 | 10769 | ||||||
| 2023-01-10 | 4 | FORM 4 | 0001567619-23-000770 | 7924 | ||||||
| 2023-01-05 | 8-K | RE REINCORPORATION | 3.03,9.01 | 0001021771-23-000002 | 001-37603 | 23512149 | 34 | 27905855 | 1 | 1 |
| 2022-12-28 | 4 | FORM 4 | 0001567619-22-022055 | 9343 | ||||||
| 2022-12-07 | 4 | FORM 4 | 0001567619-22-021408 | 8387 | ||||||
| 2022-11-21 | 4 | FORM 4 | 0001567619-22-020707 | 19373 | ||||||
| 2022-11-21 | 4 | FORM 4 | 0001567619-22-020651 | 8387 | ||||||
| 2022-11-14 | 10-Q | form10-q.htm | 0001493152-22-031668 | 001-37603 | 221380696 | 34 | 4230453 | 1 | 1 | |
| 2022-11-09 | 8-K | ANNUAL SHAREHOLDER MEETING | 5.07 | 0001021771-22-000060 | 001-37603 | 221373416 | 34 | 178950 | 1 | 1 |
| 2022-11-04 | 4 | FORM 4 | 0001567619-22-019201 | 7794 | ||||||
| 2022-11-04 | 4 | FORM 4 | 0001567619-22-019198 | 24778 | ||||||
| 2022-11-04 | 4 | FORM 4 | 0001567619-22-019195 | 8354 | ||||||
| 2022-11-04 | 4 | FORM 4 | 0001567619-22-019193 | 7847 | ||||||
| 2022-11-04 | 4 | FORM 4 | 0001567619-22-019191 | 7815 | ||||||
| 2022-11-04 | 4 | FORM 4 | 0001567619-22-019189 | 7774 | ||||||
| 2022-11-04 | 4 | FORM 4 | 0001567619-22-019187 | 13312 | ||||||
| 2022-10-12 | 4 | FORM 4 | 0001567619-22-018437 | 19426 | ||||||
| 2022-10-12 | 4 | FORM 4 | 0001567619-22-018424 | 19905 | ||||||
| 2022-10-04 | EFFECT | xslEFFECTX01/primary_doc.xml | POS AM,0001021771-22-000056,2022-10-04 | 9999999995-22-002911 | 333-258611 | 221294450 | 33 | 1805 | ||
| 2022-09-30 | POS AM | AMENDMENT 1 TO POST EFFECTIVE AMENDMENT 1 TO FORM S-1 ON FORM S-3 | 0001021771-22-000056 | 333-258611 | 221285047 | 33 | 805096 | |||
| 2022-09-27 | 4 | FORM 4 | 0001567619-22-017856 | 11404 | ||||||
| 2022-09-23 | DEF 14A | ANNUAL MEETING PROXY STATEMENT | 0001021771-22-000053 | 001-37603 | 221262474 | 34 | 2404597 | |||
| 2022-09-23 | 4 | FORM 4 | 0001567619-22-017754 | 9403 | ||||||
| 2022-09-13 | 8-K | FORM 8-K RE CERTIFICATE OF DESIGNATION SERIES B | 1.01,4.01,5.03,7.01,9.01 | 0001021771-22-000051 | 001-37603 | 221241140 | 34 | 22795180 | 1 | 1 |
| 2022-09-09 | 4 | FORM 4 | 0001567619-22-017246 | 24726 | ||||||
| 2022-08-16 | POS AM | POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-1 ON FORM S-3 | 0001021771-22-000048 | 333-258611 | 221170307 | 33 | 810335 | |||
| 2022-08-15 | 10-Q | form10-q.htm | 0001493152-22-022617 | 001-37603 | 221162661 | 34 | 4823209 | 1 | 1 | |
| 2022-08-05 | PRE 14A | 2022 ANNUAL MEETING PROXY STATEMENT | 0001021771-22-000042 | 001-37603 | 221140972 | 34 | 2901385 | |||
| 2022-07-15 | 4 | FORM 4 | 0001567619-22-014051 | 14721 | ||||||
| 2022-07-14 | SC 13G | BRTX_13g_22_v1.htm | 0001700205-22-000002 | 005-86699 | 221083654 | 34 | 109188 | |||
| 2022-07-13 | 4 | FORM 4 | 0001567619-22-013928 | 8474 | ||||||
| 2022-07-05 | 4 | FORM 4 | 0001567619-22-013688 | 11886 | ||||||
| 2022-07-01 | 4 | FORM 4 | 0001567619-22-013553 | 8479 | ||||||
| 2022-06-23 | 424B3 | 1,856,938 SHARES OF COMMON STOCK | 0001021771-22-000031 | 333-265052 | 221036198 | 33 | 127373 | |||
| 2022-06-23 | 4 | FORM 4 | 0001567619-22-013309 | 13305 | ||||||
| 2022-06-21 | SC 13D/A | DALE BROADRICK SCHEDULE 13D AMENDMENT 8 | 0001021771-22-000029 | 005-86699 | 221026449 | 34 | 77253 | |||
| 2022-06-17 | 4 | FORM 4 | 0001567619-22-013111 | 13790 | ||||||
| 2022-06-17 | 4 | FORM 4 | 0001567619-22-013067 | 8489 | ||||||
| 2022-06-16 | EFFECT | xslEFFECTX01/primary_doc.xml | S-3,,2022-06-16 17:00:00 | 9999999995-22-001804 | 333-265052 | 221022308 | 33 | 1792 | ||
| 2022-06-15 | 4 | FORM 4 | 0001567619-22-012912 | 5949 | ||||||
| 2022-06-15 | 4 | FORM 4 | 0001567619-22-012910 | 8494 | ||||||
| 2022-06-15 | 4 | FORM 4 | 0001567619-22-012901 | 11886 | ||||||
| 2022-06-15 | 4 | FORM 4 | 0001567619-22-012893 | 20674 | ||||||
| 2022-06-15 | 4 | FORM 4 | 0001567619-22-012867 | 8495 | ||||||
| 2022-06-14 | 4 | FORM 4 | 0001567619-22-012812 | 9470 | ||||||
| 2022-06-13 | CORRESP | filename1.htm | 0001021771-22-000027 | 7289 | ||||||
| 2022-06-13 | 4 | FORM 4 | 0001567619-22-012747 | 13789 | ||||||
| 2022-06-09 | 4 | FORM 4 | 0001567619-22-012605 | 13791 | ||||||
| 2022-06-09 | 4 | FORM 4 | 0001567619-22-012581 | 8010 | ||||||
| 2022-06-08 | 4 | FORM 4 | 0001567619-22-012496 | 21152 | ||||||
| 2022-06-07 | 4 | FORM 4 | 0001567619-22-012430 | 13790 | ||||||
| 2022-06-07 | 4 | FORM 4 | 0001567619-22-012416 | 5949 | ||||||
| 2022-06-06 | 4 | FORM 4 | 0001567619-22-012367 | 11885 | ||||||
| 2022-06-03 | 4 | FORM 4 | 0001567619-22-012250 | 11885 | ||||||
| 2022-06-03 | 4 | FORM 4 | 0001567619-22-012211 | 8008 | ||||||
| 2022-06-01 | 4 | FORM 4 | 0001567619-22-012010 | 11888 | ||||||
| 2022-05-31 | 4 | FORM 4 | 0001567619-22-011949 | 13784 | ||||||
| 2022-05-27 | 4 | FORM 4 | 0001567619-22-011807 | 8495 | ||||||
| 2022-05-20 | UPLOAD | filename1.pdf | 0000000000-22-005592 | 40257 | ||||||
| 2022-05-18 | S-3 | PROSPECTUS DATED MAY 13, 2022 | 0001021771-22-000025 | 333-265052 | 22939162 | 33 | 287154 | |||
| 2022-05-16 | 10-Q | form10-q.htm | 0001493152-22-013396 | 001-37603 | 22924242 | 34 | 4480935 | 1 | 1 | |
| 2022-05-02 | 4 | FORM 4 | 0001567619-22-009300 | 9456 | ||||||
| 2022-04-11 | 4 | FORM 4 | 0001567619-22-008332 | 5949 | ||||||
| 2022-04-08 | 4 | FORM 4 | 0001567619-22-008301 | 11402 | ||||||
| 2022-04-07 | 4 | FORM 4 | 0001567619-22-008245 | 12823 | ||||||
| 2022-04-07 | SC 13D/A | DALE BROADRICK SCHEDULE 13D AMENDMENT 7 | 0001021771-22-000019 | 005-86699 | 22813937 | 34 | 60053 | |||
| 2022-04-01 | 4 | FORM 4 | 0001567619-22-007864 | 14566 | ||||||
| 2022-03-30 | 10-K | form10k.htm | 0001493152-22-008184 | 001-37603 | 22787138 | 34 | 17175037 | 1 | 1 | |
| 2022-03-29 | 4 | FORM 4 | 0001567619-22-007664 | 22696 | ||||||
| 2022-03-29 | SC 13D/A | DALE BROADRICK SCHEDULE 13D AMENDMENT 6 | 0001021771-22-000014 | 005-86699 | 22781586 | 34 | 79478 | |||
| 2022-03-22 | 4 | FORM 4 | 0001567619-22-007349 | 22032 | ||||||
| 2022-03-22 | 4 | FORM 4 | 0001567619-22-007347 | 8173 | ||||||
| 2022-02-14 | SC 13G/A | AMENDMENT TO SC 13G | 0001387131-22-001750 | 005-86699 | 22624491 | 34 | 101837 | |||
| 2022-02-02 | SC 13G | BRTX 13G | 0001393825-22-000015 | 005-86699 | 22584083 | 34 | 61624 | |||
| 2022-01-24 | 4 | FORM 4 | 0001567619-22-001588 | 7840 | ||||||
| 2022-01-05 | 4 | FORM 4 | 0001567619-22-000585 | 7841 | ||||||
| 2022-01-04 | SC 13G/A | SABBY 13G-A BRTX 1.04.22 | 0001535610-22-000030 | 005-86699 | 22505588 | 34 | 13321 | |||
| 2021-12-08 | 8-K | RE CFO | 5.02,9.01 | 0001021771-21-000099 | 001-37603 | 211479225 | 34 | 274135 | 1 | 1 |
| 2021-12-02 | 4 | FORM 4 | 0001567619-21-021415 | 7840 | ||||||
| 2021-11-23 | 4 | FORM 4 | 0001567619-21-021072 | 7842 | ||||||
| 2021-11-23 | RW | REQUESTFORWITHDRAWAL | 0001021771-21-000097 | 333-231079 | 211438768 | NE | 6112 | |||
| 2021-11-22 | 4 | FORM 4 | 0001567619-21-020992 | 7841 | ||||||
| 2021-11-22 | 4 | FORM 4 | 0001567619-21-020924 | 23369 | ||||||
| 2021-11-19 | 8-K | 8-K DATED NOVEMBER 16, 2021 RE AUTHORIZED SHARE REDUCTION | 5.03,9.01 | 0001021771-21-000092 | 001-37603 | 211427597 | 34 | 1038098 | 1 | 1 |
| 2021-11-16 | 4 | FORM 4 | 0001567619-21-020595 | 12697 | ||||||
| 2021-11-16 | 4 | FORM 4 | 0001567619-21-020585 | 25047 | ||||||
| 2021-11-16 | 4 | FORM 4 | 0001567619-21-020581 | 5376 | ||||||
| 2021-11-16 | 3 | FORM 3 | 0001567619-21-020579 | 3660 | ||||||
| 2021-11-16 | SC 13G | SCHEDULE FILED TO REPORT ACQUISITION OF BENEFICIAL OWNERSHIP | 0001387131-21-011159 | 005-86699 | 211413750 | 34 | 97317 | |||
| 2021-11-15 | 10-Q | form10q.htm | 0001493152-21-028733 | 001-37603 | 211412243 | 34 | 6642852 | 1 | 1 | |
| 2021-11-15 | 8-K | FORM 8-K DATED NOVEMBER 9, 2021 RE PUBLIC OFFERING | 3.02,7.01,9.01 | 0001021771-21-000089 | 001-37603 | 211411973 | 34 | 12419868 | 1 | 1 |
| 2021-11-09 | SC 13G | SABBY 13G BRTX 11.09.21 | 0001535610-21-000099 | 005-86699 | 211391007 | 34 | 13321 | |||
| 2021-11-09 | 424B4 | form424b4.htm | 0001493152-21-027544 | 333-258611 | 211389181 | 33 | 3159733 | |||
| 2021-11-08 | 4 | FORM 4 | 0001567619-21-019510 | 5368 | ||||||
| 2021-11-08 | 3 | FORM 3 | 0001567619-21-019508 | 3651 | ||||||
| 2021-11-08 | 4 | FORM 4 | 0001567619-21-019503 | 5409 | ||||||
| 2021-11-08 | 3 | FORM 3 | 0001567619-21-019500 | 3693 | ||||||
| 2021-11-08 | 4 | FORM 4 | 0001567619-21-019498 | 29066 | ||||||
| 2021-11-08 | 4 | FORM 4 | 0001567619-21-019496 | 5441 | ||||||
| 2021-11-08 | 4 | FORM 4 | 0001567619-21-019494 | 11535 | ||||||
| 2021-11-08 | 8-K | FORM 8-K DATED NOVEMBER 4, 2021 | 1.01,5.02,7.01,9.01 | 0001021771-21-000087 | 001-37603 | 211388853 | 34 | 14783500 | 1 | 1 |
| 2021-11-04 | EFFECT | xslEFFECTX01/primary_doc.xml | S-1,,2021-11-04 17:00:00 | 9999999995-21-004196 | 333-258611 | 211382145 | 33 | 1792 | ||
| 2021-11-04 | S-1MEF | forms-1mef.htm | 0001493152-21-027276 | 333-260792 | 211381884 | 33 | 78905 | |||
| 2021-11-04 | CERT | 8A_Cert_BRTX.pdf | 0001354457-21-001292 | 001-37603 | 211379880 | 34 | 216090 | |||
| 2021-11-04 | 8-A12B | REGISTRATION OF COMMON STOCK | 0001021771-21-000082 | 001-37603 | 211379736 | 34 | 14452 | |||
| 2021-11-04 | CORRESP | filename1.htm | 0001021771-21-000080 | 5139 | ||||||
| 2021-11-04 | CORRESP | filename1.htm | 0001021771-21-000078 | 9489 | ||||||
| 2021-11-04 | S-1/A | forms-1a.htm | 0001493152-21-027195 | 333-258611 | 211378221 | 33 | 16751491 | 1 | 1 | |
| 2021-10-29 | S-1/A | forms-1a.htm | 0001493152-21-026766 | 333-258611 | 211364426 | 33 | 16581595 | 1 | 1 | |
| 2021-10-26 | 8-K | FORM 8-K DATED OCTOBER 26, 2021 RE REVERSE SPLIT | 5.03,8.01,9.01 | 0001021771-21-000076 | 001-37603 | 211349549 | 34 | 2544616 | 1 | 1 |
| 2021-10-20 | 8-K | FORM 8-K DATED OCTOBER 14, 2021 | 1.01,9.01 | 0001021771-21-000074 | 001-37603 | 211334868 | 34 | 6684321 | 1 | 1 |
| 2021-10-18 | S-1/A | forms-1a.htm | 0001493152-21-025629 | 333-258611 | 211327145 | 33 | 15686321 | 1 | 1 | |
| 2021-08-17 | 8-K | 8-K DATED AUGUST 17, 2021 RE: SHAREHOLDER VOTE | 5.07 | 0001021771-21-000066 | 001-37603 | 211183244 | 34 | 177111 | 1 | 1 |
| 2021-08-16 | 10-Q | form10-q.htm | 0001493152-21-019979 | 001-37603 | 211175337 | 34 | 5902913 | 1 | 1 | |
| 2021-08-13 | UPLOAD | filename1.pdf | 0000000000-21-009978 | 40267 | ||||||
| 2021-08-12 | DEFA14A | DEFINITIVE ADDITIONAL PROXY MATERIALS | 0001021771-21-000061 | 001-37603 | 211168050 | 34 | 34785 | |||
| 2021-08-06 | S-1 | forms-1.htm | 0001493152-21-018939 | 333-258611 | 211155495 | 33 | 3460029 | |||
| 2021-07-19 | DEFA14A | definitiveaddmaterials.htm | 0001021771-21-000057 | 001-37603 | 211098145 | 34 | 26848 | |||
| 2021-07-07 | DEF 14A | ANNUAL MEETING OF STOCKHOLDERS AUGUST 17, 2021 | 0001021771-21-000049 | 001-37603 | 211076332 | 34 | 2689433 | |||
| 2021-06-25 | PRE 14A | PRELIMINARY PROXY STATEMENT RE ANNUAL MEETING | 0001021771-21-000042 | 001-37603 | 211048496 | 34 | 915056 | |||
| 2021-05-17 | 10-Q | form10-q.htm | 0001493152-21-011738 | 001-37603 | 21929144 | 34 | 4241378 | 1 | ||
| 2021-04-30 | S-8 | S-8 REGISTRATION STATEMENT | 0001021771-21-000034 | 333-255681 | 21879112 | 33 | 123709 | |||
| 2021-04-30 | 10-K | form10-k.htm | 0001493152-21-010062 | 001-37603 | 21872475 | 34 | 7438634 | 1 | ||
| 2021-04-12 | 10-Q | form10-q.htm | 0001493152-21-008499 | 001-37603 | 21819655 | 34 | 5050581 | 1 | ||
| 2021-04-12 | 10-Q | form10-q.htm | 0001493152-21-008498 | 001-37603 | 21819605 | 34 | 4751979 | 1 | ||
| 2021-04-05 | 8-K/A | FORM 8-K AMENDMENT NO. 1 | 5.02,9.01 | 0001021771-21-000028 | 001-37603 | 21806064 | 34 | 23694 | ||
| 2021-04-01 | NT 10-K | BIORESTORATIVE THERAPIES, INC. FORM 12B-25 10-K 2020 | 0001021771-21-000026 | 001-37603 | 21798567 | 34 | 26255 | |||
| 2021-03-29 | 10-Q | form10-q.htm | 0001493152-21-006978 | 001-37603 | 21779401 | 34 | 4305739 | 1 | ||
| 2021-03-19 | 3 | FORM 3 | 0001567619-21-006694 | 3634 | ||||||
| 2021-03-19 | 4 | FORM 4 | 0001567619-21-006692 | 27907 | ||||||
| 2021-03-19 | 4 | FORM 4 | 0001567619-21-006690 | 7309 | ||||||
| 2021-03-19 | SC 13D | FRANCISCO SILVA SCHEDULE 13D | 0001021771-21-000024 | 005-86699 | 21758863 | 34 | 44590 | |||
| 2021-03-19 | SC 13D | LANCE ALSTODT SCHEDULE 13D | 0001021771-21-000022 | 005-86699 | 21758834 | 34 | 44189 | |||
| 2021-03-19 | 8-K | BIORESTORATIVE FORM 8-K DATED MARCH 18, 2021 | 5.02,9.01 | 0001021771-21-000020 | 001-37603 | 21758806 | 34 | 523777 | ||
| 2021-03-18 | 10-K | form10-k.htm | 0001493152-21-006285 | 001-37603 | 21751962 | 34 | 9294382 | 1 | ||
| 2021-01-06 | 8-K | FORM 8-K DATED JANUARY 5, 2021 RE: LETTER TO SHAREHOLDERS | 7.01,9.01 | 0001021771-21-000002 | 001-37603 | 21511415 | 34 | 3684264 | ||
| 2020-12-04 | 8-K | FORM 8-K DATED DECEMBER 1, 2020 RE: CHANGE IN ACCOUNTANTS | 4.01,9.01 | 0001021771-20-000083 | 001-37603 | 201370182 | 34 | 510585 | ||
| 2020-11-24 | 4 | FORM 4 | 0001567619-20-020268 | 4859 | ||||||
| 2020-11-24 | 4 | FORM 4 | 0001567619-20-020265 | 25454 | ||||||
| 2020-11-20 | 8-K | FORM 8-K DATED NOVEMBER 16, 2020 RE: REORGANIZATION | 1.03,2.03,3.02,5.02,5.03,9.01 | 0001021771-20-000081 | 001-37603 | 201333144 | 34 | 57156 | ||
| 2020-11-05 | 8-K | FORM 8-K DATED OCTOBER 30, 2020 RE: ORDER OF BANKRUPTCY COURT | 1.03,9.01 | 0001021771-20-000079 | 001-37603 | 201291275 | 34 | 26716294 | ||
| 2020-04-28 | 8-K | FORM 8K DATED APRIL 23, 2020 | 1.01,1.03,9.01 | 0001021771-20-000044 | 001-37603 | 20825273 | 34 | 124529 | ||
| 2020-04-03 | 8-K | FORM 8-K DATED MARCH 30, 2020 | 1.01,1.03,9.01 | 0001021771-20-000041 | 001-37603 | 20774130 | 34 | 696013 | ||
| 2020-03-31 | NT 10-K | FORM 12B-25 FOR PERIOD ENDED DECEMBER 31, 2019 | 0001021771-20-000038 | 001-37603 | 20761871 | 34 | 29529 | |||
| 2020-03-20 | 8-K | FORM 8-K DATED MARCH 16, 2020 | 1.01,1.03,2.04,5.02,7.01,9.01 | 0001021771-20-000036 | 001-37603 | 20731999 | 34 | 757777 | ||
| 2020-03-05 | 8-K | FORM 8-K DATED FEBRUARY 28, 2020 | 3.02 | 0001021771-20-000031 | 001-37603 | 20691126 | 34 | 16822 | ||
| 2020-02-26 | 8-K | FORM 8-K DATED FEBRUARY 20, 2020 | 1.01,2.03,3.02,5.02,9.01 | 0001021771-20-000029 | 001-37603 | 20655869 | 34 | 33270286 | ||
| 2020-02-20 | 8-K | FEBRUARY 20, 2020 | 3.02 | 0001021771-20-000027 | 001-37603 | 20635709 | 34 | 27184 | ||
| 2020-02-14 | 8-K | FORM 8-K DATED FEBRUARY 13, 2020 | 7.01 | 0001021771-20-000025 | 001-37603 | 20621235 | 34 | 16012 | ||
| 2020-02-11 | 8-K | FORM 8-K DATED FEBRUARY 10, 2020 | 2.04,3.02,7.01,9.01 | 0001021771-20-000023 | 001-37603 | 20598264 | 34 | 1845269 | ||
| 2020-02-07 | 8-K | form8k020320.htm | 3.02,7.01 | 0001021771-20-000019 | 001-37603 | 20587984 | 34 | 20350 | ||
| 2020-01-31 | 8-K | FORM 8-K DATED JANUARY 27, 2020 | 3.02 | 0001021771-20-000014 | 001-37603 | 20566079 | 34 | 17497 | ||
| 2020-01-24 | 8-K | FORM 8-K DATED JANUARY 20, 2020 | 3.02 | 0001021771-20-000012 | 001-37603 | 20546135 | 34 | 16704 | ||
| 2020-01-16 | 8-K | FORM 8-K DATED JANUARY 10, 2020 | 3.02,5.02 | 0001021771-20-000008 | 001-37603 | 20531406 | 34 | 19495 | ||
| 2020-01-10 | 8-K | FORM 8-K DATED JANUARY 8, 2020 | 3.02,5.02,5.07,9.01 | 0001021771-20-000006 | 001-37603 | 20521905 | 34 | 1580087 | ||
| 2020-01-09 | SC 13D/A | DALE BROADRICK SCHEDULE 13D AMENDMENT NO. 5 | 0001021771-20-000004 | 005-86699 | 20516810 | 34 | 52258 | |||
| 2020-01-08 | 4 | FORM 4 | 0001567619-20-000794 | 13255 | ||||||
| 2020-01-07 | 8-K | BIORESTORATIVE FORM 8-K DATED DECEMBER 31, 2019 | 3.02 | 0001021771-20-000002 | 001-37603 | 20513956 | 34 | 16050 | ||
| 2019-12-27 | SC 13G | SCHEDULE 13G | 0001078782-19-000952 | 005-86699 | 191311326 | 34 | 44416 | |||
| 2019-12-26 | 8-K | FORM 8-K DATED DECEMBER 19, 2019 | 1.01,3.02 | 0001021771-19-000098 | 001-37603 | 191310908 | 34 | 18293 | ||
| 2019-12-23 | DEF 14A | def14a.htm | 0001493152-19-019634 | 001-37603 | 191306886 | 34 | 276162 | |||
| 2019-12-18 | 8-K | FORM 8-K DATED DECEMBER 12, 2019 | 3.02 | 0001021771-19-000096 | 001-37603 | 191293260 | 34 | 17425 | ||
| 2019-12-13 | PRE 14A | JANUARY 8, 2020 SPECIAL MEETING | 0001021771-19-000094 | 001-37603 | 191285389 | 34 | 1824491 | |||
| 2019-12-10 | 4 | FORM 4 | 0001567619-19-022842 | 42363 | ||||||
| 2019-12-10 | SC 13D/A | DALE BROADRICK SCHEDULE 13D AMENDMENT 4 | 0001021771-19-000092 | 005-86699 | 191278474 | 34 | 57914 | |||
| 2019-12-06 | 8-K | FORM 8-K DATED DECEMBER 2, 2019 | 3.02 | 0001021771-19-000089 | 001-37603 | 191273490 | 34 | 16782 | ||
| 2019-11-26 | 8-K | FORM 8-K DATED NOVEMBER 20, 2019. | 3.02 | 0001021771-19-000087 | 001-37603 | 191252181 | 34 | 17785 | ||
| 2019-11-15 | 8-K | FORM 8-K DATED NOVEMBER 13, 2019 RE: SPECIAL MEETING | 5.07,9.01 | 0001021771-19-000083 | 001-37603 | 191224961 | 34 | 1674203 | ||
| 2019-11-13 | 10-Q | form10-q.htm | 0001493152-19-017053 | 001-37603 | 191214706 | 34 | 5279314 | 1 | ||
| 2019-11-05 | 8-K | FORM 8-K DATED OCTOBER 30, 2019 | 3.02 | 0001021771-19-000081 | 001-37603 | 191194045 | 34 | 16684 | ||
| 2019-11-01 | DEFA14A | ARENA PURCHASE AGREEMENT TERMINATION | 0001021771-19-000079 | 001-37603 | 191187604 | 34 | 18425 | |||
| 2019-11-01 | 8-K | FORM 8-K DATED NOVEMBER 1, 2019 RE: ARENA PURCHASE AGREEMENT TERMINATION | 1.02 | 0001021771-19-000077 | 001-37603 | 191187573 | 34 | 13537 | ||
| 2019-11-01 | SC 13D/A | DALE BROADRICK SCHEDULE 13D AMENDMENT NO. 3 | 0001021771-19-000075 | 005-86699 | 191187224 | 34 | 53766 | |||
| 2019-11-01 | 4 | FORM 4 | 0001567619-19-020298 | 17229 | ||||||
| 2019-10-28 | DEF 14A | NOVEMBER 2019 SPECIAL MEETING PROXY STATEMENT | 0001021771-19-000073 | 001-37603 | 191173650 | 34 | 2078468 | |||
| 2019-10-22 | 8-K | FORM 8-K DATED OCTOBER 16, 2019 | 1.01,3.02,9.01 | 0001021771-19-000071 | 001-37603 | 191162113 | 34 | 19607 | ||
| 2019-10-18 | PRE 14A | PRELIMINARY PROXY STATEMENT SPECIAL MEETING NOVEMBER 12, 2019 | 0001021771-19-000069 | 001-37603 | 191158852 | 34 | 2091402 | |||
| 2019-10-18 | SC 13D/A | DALE BROADRICK - BIORESTORATIVE THERAPIES, INC. SCHEDULE 13D AMENDMENT 2 | 0001021771-19-000063 | 005-86699 | 191157930 | 34 | 154431 | |||
| 2019-10-18 | 4 | FORM 4 | 0001567619-19-019742 | 59105 | ||||||
| 2019-10-18 | 4/A | FORM 4/A | 0001567619-19-019733 | 12416 | ||||||
| 2019-10-10 | 8-K | 8-K OCTOBER 7, 2019 | 1.01,2.03,3.02,9.01 | 0001021771-19-000061 | 001-37603 | 191146714 | 34 | 187326 | ||
| 2019-10-04 | 8-K | FORM 8-K DATED SEPTEMBER 30, 2019 | 3.02 | 0001021771-19-000056 | 001-37603 | 191139011 | 34 | 16352 | ||
| 2019-09-10 | 4 | FORM 4 | 0001567619-19-018128 | 10342 | ||||||
| 2019-09-06 | S-1/A | forms-1a.htm | 0001493152-19-013825 | 333-231079 | 191080442 | 33 | 12656799 | 1 | ||
| 2019-09-06 | 8-K | FORM 8-K DATED AUGUST 30, 2019 | 3.02,5.07,7.01,9.01 | 0001021771-19-000051 | 001-37603 | 191080356 | 34 | 15519162 | ||
| 2019-09-06 | 4 | FORM 4 | 0001567619-19-018008 | 7511 | ||||||
| 2019-09-06 | 4 | FORM 4 | 0001567619-19-018006 | 26572 | ||||||
| 2019-09-06 | 4 | FORM 4 | 0001567619-19-018004 | 22358 | ||||||
| 2019-09-03 | 4 | FORM 4 | 0001567619-19-017786 | 27990 | ||||||
| 2019-09-03 | 4 | FORM 4 | 0001567619-19-017784 | 13879 | ||||||
| 2019-08-29 | 4 | FORM 4 | 0001567619-19-017679 | 15298 | ||||||
| 2019-08-29 | 4 | FORM 4 | 0001567619-19-017677 | 18197 | ||||||
| 2019-08-29 | 4 | FORM 4 | 0001567619-19-017673 | 22351 | ||||||
| 2019-08-28 | 4 | FORM 4 | 0001567619-19-017635 | 26003 | ||||||
| 2019-08-27 | 4 | FORM 4 | 0001567619-19-017607 | 8925 | ||||||
| 2019-08-27 | 4 | FORM 4 | 0001567619-19-017605 | 18197 | ||||||
| 2019-08-27 | 8-K | form8k82119.htm | 3.02 | 0001021771-19-000049 | 001-37603 | 191058363 | 34 | 20487 | ||
| 2019-08-23 | 4 | FORM 4 | 0001567619-19-017530 | 26002 | ||||||
| 2019-08-23 | 4 | FORM 4 | 0001567619-19-017528 | 11742 | ||||||
| 2019-08-23 | 4 | FORM 4 | 0001567619-19-017526 | 20932 | ||||||
| 2019-08-22 | 4 | FORM 4 | 0001567619-19-017492 | 7504 | ||||||
| 2019-08-15 | S-8 | REGISTRATION OF 10,000,000 SHARES | 0001021771-19-000047 | 333-233309 | 191030965 | 33 | 75398 | |||
| 2019-08-15 | DEF 14A | SPECIAL MEETING PROXY STATEMENT | 0001021771-19-000045 | 001-37603 | 191030913 | 34 | 7032030 | |||
| 2019-08-14 | 10-Q | form10-q.htm | 0001493152-19-012593 | 001-37603 | 191027167 | 34 | 4911400 | 1 | ||
| 2019-08-02 | PRE 14A | PRELIMINARY PROXY STATEMENT RE: 2019 SPECIAL MEETING | 0001021771-19-000042 | 001-37603 | 19996710 | 34 | 6385105 | |||
| 2019-08-01 | 8-K | BIORESTORATIVE FORM 8-K DATED JULY 26, 2019 | 1.01,2.03,3.02,9.01 | 0001021771-19-000039 | 001-37603 | 19993371 | 34 | 1903977 | ||
| 2019-07-17 | 8-K | FORM 8-K DATED JULY 11, 2019 | 3.02 | 0001021771-19-000037 | 001-37603 | 19959360 | 34 | 18910 | ||
| 2019-06-24 | 8-K | FORM 8-K DATED JUNE 18, 2019 | 1.01,2.03,3.02,9.01 | 0001021771-19-000035 | 001-37603 | 19915278 | 34 | 34035365 | ||
| 2019-06-12 | 8-K | FORM 8-K DATED JUNE 6, 2019 RE: ITEM 302 | 3.02 | 0001021771-19-000033 | 001-37603 | 19893921 | 34 | 18844 | ||
| 2019-06-04 | 8-K | FORM 8-K RE: ANNUAL MEETING | 5.07,9.01 | 0001021771-19-000030 | 001-37603 | 19874570 | 34 | 50535 | ||
| 2019-05-29 | 8-K | FORM 8-K DATED MAY 22, 2019 | 3.02 | 0001021771-19-000028 | 001-37603 | 19862324 | 34 | 17434 | ||
| 2019-05-15 | 10-Q | form10-q.htm | 0001493152-19-007157 | 001-37603 | 19824691 | 34 | 3796123 | 1 | ||
| 2019-05-13 | 8-K | FORM 8-K DATED MAY 7, 2019 | 1.01,3.02,9.01 | 0001021771-19-000026 | 001-37603 | 19819197 | 34 | 22372 | ||
| 2019-05-09 | SC 13D/A | DALE BROADRICK - BIORESTORATIVE THERAPIES, INC. SCHEDULE 13D AMENDMENT 1 | 0001021771-19-000024 | 005-86699 | 19811399 | 34 | 13078250 | |||
| 2019-05-09 | 4 | FORM 4 | 0001567619-19-010301 | 27109 | ||||||
| 2019-04-30 | 8-K | FORM 8-K RE: PRESENTATION | 7.01,9.01 | 0001021771-19-000022 | 001-37603 | 19782126 | 34 | 11732849 | ||
| 2019-04-26 | S-1 | forms-1.htm | 0001493152-19-006013 | 333-231079 | 19772412 | 33 | 9121183 | 1 | ||
| 2019-04-24 | 8-K | FORM 8-K DATED APRIL 18, 2019 | 3.02 | 0001021771-19-000020 | 001-37603 | 19764426 | 34 | 19911 | ||
| 2019-04-18 | DEF 14A | BIORESTORATIVE PROXY STATEMENT APRIL 17, 2019 | 0001021771-19-000018 | 001-37603 | 19756376 | 34 | 2403686 | |||
| 2019-04-05 | PRE 14A | MAY 30, 2019 PROXY STATEMENT | 0001021771-19-000016 | 001-37603 | 19735661 | 34 | 3694528 |
One latest value per concept from companyfacts (426 concepts). Full history stays in the JSON.
| Taxonomy | Tag | Label | Unit | Value | Start | End | FY | FP | Form | Filed | Accn |
|---|---|---|---|---|---|---|---|---|---|---|---|
| dei | EntityCommonStockSharesOutstanding | Entity Common Stock, Shares Outstanding | shares | 25.48M | 2026-05-14 | 2026 | Q1 | 10-Q | 2026-05-14 | 0001493152-26-023126 | |
| dei | EntityPublicFloat | Entity Public Float | USD | 11.20M | 2025-06-30 | 2025 | FY | 10-K | 2026-03-26 | 0001493152-26-012925 | |
| ffd | NetFeeAmt | NetFeeAmt | USD | 0 | 2026-04-20 | POS AM | 2026-04-20 | 0001493152-26-018143 | |||
| ffd | TtlFeeAmt | TtlFeeAmt | USD | 2,882.83 | 2026-04-20 | POS AM | 2026-04-20 | 0001493152-26-018143 | |||
| ffd | TtlOfferingAmt | TtlOfferingAmt | USD | 20.88M | 2026-04-20 | POS AM | 2026-04-20 | 0001493152-26-018143 | |||
| ffd | TtlOffsetAmt | TtlOffsetAmt | USD | 0 | 2026-04-20 | POS AM | 2026-04-20 | 0001493152-26-018143 | |||
| ffd | TtlPrevslyPdAmt | TtlPrevslyPdAmt | USD | 2,882.83 | 2026-04-20 | POS AM | 2026-04-20 | 0001493152-26-018143 | |||
| invest | InvestmentWarrantsExercisePrice | Investment Warrants, Exercise Price | USD | 4 | 2017-01-01 | 2017-09-30 | 2017 | Q3 | 10-Q | 2017-11-14 | 0001493152-17-013246 |
| us-gaap | AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent | Accounts Payable and Accrued Liabilities | USD | 112,000 | 2015-12-31 | 2015 | FY | 10-K | 2016-03-30 | 0001144204-16-091575 | |
| us-gaap | AccountsPayableAndAccruedLiabilitiesNoncurrent | Accounts Payable and Accrued Liabilities, Noncurrent | USD | 36,500 | 2018-12-31 | 2019 | FY | 10-K | 2021-03-18 | 0001493152-21-006285 | |
| us-gaap | AccountsPayableCurrent | Accounts Payable, Current | USD | 666,898 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-14 | 0001493152-26-023126 | |
| us-gaap | AccountsPayableCurrentAndNoncurrent | Accounts Payable | USD | 265,297 | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-11-13 | 0001493152-19-017053 | |
| us-gaap | AccountsReceivableNetCurrent | Accounts Receivable, after Allowance for Credit Loss, Current | USD | 13,300 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-14 | 0001493152-26-023126 | |
| us-gaap | AccretionExpense | Accretion Expense | USD | 2.81M | 2020-01-01 | 2020-12-31 | 2021 | FY | 10-K | 2022-03-30 | 0001493152-22-008184 |
| us-gaap | AccruedBonusesCurrentAndNoncurrent | Accrued Bonuses | USD | 91,000 | 2018-12-31 | 2019 | FY | 10-K | 2021-03-18 | 0001493152-21-006285 | |
| us-gaap | AccruedLiabilitiesAndOtherLiabilities | Accrued Liabilities and Other Liabilities | USD | 744,485 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-28 | 0001641172-25-001011 | |
| us-gaap | AccruedLiabilitiesCurrent | Accrued Liabilities, Current | USD | 744,485 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-28 | 0001641172-25-001011 | |
| us-gaap | AccruedLiabilitiesCurrentAndNoncurrent | Accrued Liabilities | USD | 92,000 | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-11-13 | 0001493152-19-017053 | |
| us-gaap | AccruedProfessionalFeesCurrent | Accrued Professional Fees, Current | USD | 137,122 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-14 | 0001493152-26-023126 | |
| us-gaap | AccruedRentCurrent | Accrued Rent, Current | USD | 7,865 | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-11-13 | 0001493152-19-017053 | |
| us-gaap | AccruedRentCurrentAndNoncurrent | Accrued Rent | USD | 12,438 | 2019-12-31 | 2020 | FY | 10-K | 2021-04-30 | 0001493152-21-010062 | |
| us-gaap | AccruedSalariesCurrentAndNoncurrent | Accrued Salaries | USD | 557,500 | 2019-12-31 | 2020 | FY | 10-K | 2021-04-30 | 0001493152-21-010062 | |
| us-gaap | AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment | Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment | USD | 1.23M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001493152-26-012925 | |
| us-gaap | AdditionalPaidInCapital | Additional Paid in Capital | USD | 175.10M | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-14 | 0001493152-26-023126 | |
| us-gaap | AdjustmentForAmortization | Amortization | USD | -37,264 | 2021-01-01 | 2021-06-30 | 2021 | Q2 | 10-Q | 2021-08-16 | 0001493152-21-019979 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature | Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature | USD | 166,404 | 2021-01-01 | 2021-12-31 | 2022 | FY | 10-K | 2023-03-27 | 0001493152-23-008960 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalOther | Adjustments to Additional Paid in Capital, Other | USD | 148,697 | 2025-01-01 | 2025-03-31 | 2026 | Q1 | 10-Q | 2026-05-14 | 0001493152-26-023126 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue | APIC, Share-based Payment Arrangement, Increase for Cost Recognition | USD | 1.76M | 2021-07-01 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-15 | 0001493152-21-028733 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition | APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition | USD | 3.67M | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-30 | 0001493152-22-008184 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition | USD | 1.87M | 2022-09-08 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-14 | 0001493152-22-031668 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalWarrantIssued | Adjustments to Additional Paid in Capital, Warrant Issued | USD | 179,228 | 2026-01-01 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-14 | 0001493152-26-023126 |
| us-gaap | AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities | Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities | USD | 7.99M | 2019-01-01 | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-11-13 | 0001493152-19-017053 |
| us-gaap | AdvertisingExpense | Advertising Expense | USD | 288,986 | 2018-01-01 | 2018-12-31 | 2018 | FY | 10-K | 2019-03-29 | 0001493152-19-004292 |
| us-gaap | AllocatedShareBasedCompensationExpense | Share-based Payment Arrangement, Expense | USD | 290,215 | 2026-01-01 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-14 | 0001493152-26-023126 |
| us-gaap | AllowanceForDoubtfulAccountsReceivable | Accounts Receivable, Allowance for Credit Loss | USD | 0 | 2023-12-31 | 2023 | FY | 10-K/A | 2024-06-11 | 0001493152-24-023479 | |
| us-gaap | AmortizationOfDebtDiscountPremium | Amortization of Debt Discount (Premium) | USD | 1.13M | 2021-01-01 | 2021-12-31 | 2022 | FY | 10-K | 2023-03-27 | 0001493152-23-008960 |
| us-gaap | AmortizationOfIntangibleAssets | Amortization of Intangible Assets | USD | 89,747 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001493152-26-012925 |
| us-gaap | AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | shares | 24.99M | 2026-01-01 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-14 | 0001493152-26-023126 |
| us-gaap | Assets | Assets | USD | 4.64M | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-14 | 0001493152-26-023126 | |
| us-gaap | AssetsCurrent | Assets, Current | USD | 3.80M | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-14 | 0001493152-26-023126 | |
| us-gaap | AssetsFairValueDisclosure | Assets, Fair Value Disclosure | USD | 3.89M | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-11-12 | 0001493152-25-021993 | |
| us-gaap | AvailableForSaleDebtSecuritiesAmortizedCostBasis | Debt Securities, Available-for-sale, Amortized Cost | USD | 475,438 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-14 | 0001493152-26-023126 | |
| us-gaap | CapitalExpendituresIncurredButNotYetPaid | Capital Expenditures Incurred but Not yet Paid | USD | 29,246 | 2024-01-01 | 2024-03-31 | 2025 | Q1 | 10-Q | 2025-05-14 | 0001641172-25-010299 |
| us-gaap | CapitalizedComputerSoftwareGross | Capitalized Computer Software, Gross | USD | 85,118 | 2015-12-31 | 2015 | FY | 10-K | 2016-03-30 | 0001144204-16-091575 | |
| us-gaap | Cash | Cash | USD | 17.93M | 2022-06-30 | 2022 | Q2 | 10-Q | 2022-08-15 | 0001493152-22-022617 | |
| us-gaap | CashAndCashEquivalentsAtCarryingValue | Cash and Cash Equivalents, at Carrying Value | USD | 3.11M | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-14 | 0001493152-26-023126 | |
| us-gaap | CashAndCashEquivalentsFairValueDisclosure | Cash and Cash Equivalents, Fair Value Disclosure | USD | 4.90M | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-14 | 0001493152-22-031668 | |
| us-gaap | CashAndCashEquivalentsPeriodIncreaseDecrease | Cash and Cash Equivalents, Period Increase (Decrease) | USD | 7,185 | 2008-12-30 | 2011-06-30 | 2011 | Q2 | 10-Q/A | 2011-09-14 | 0001144204-11-053024 |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations | USD | 3.11M | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-14 | 0001493152-26-023126 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | USD | 1.60M | 2026-01-01 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-14 | 0001493152-26-023126 |
| us-gaap | CashEquivalentsAtCarryingValue | Cash Equivalents, at Carrying Value | USD | 0 | 2023-12-31 | 2023 | FY | 10-K/A | 2024-06-11 | 0001493152-24-023479 | |
| us-gaap | CashFDICInsuredAmount | Cash, FDIC Insured Amount | USD | 250,000 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-14 | 0001493152-26-023126 | |
| us-gaap | CashPeriodIncreaseDecrease | Cash, Period Increase (Decrease) | USD | -346,306 | 2018-01-01 | 2018-09-30 | 2018 | Q3 | 10-Q | 2018-11-13 | 0001493152-18-015801 |
| us-gaap | CashUninsuredAmount | Cash, Uninsured Amount | USD | 2.84M | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-14 | 0001493152-26-023126 | |
| us-gaap | ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights | Class of Warrant or Right, Exercise Price of Warrants or Rights (Deprecated 2014-01-31) | USD/Warrant | 0.75 | 2014-03-31 | 2014 | Q1 | 10-Q | 2014-05-14 | 0001144204-14-030532 | |
| us-gaap | ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 | Class of Warrant or Right, Exercise Price of Warrants or Rights | USD/shares | 4 | 2017-12-31 | 2017 | FY | 10-K | 2018-04-02 | 0001493152-18-004554 | |
| us-gaap | ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights | Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares | 4.50M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001493152-26-012925 | |
| us-gaap | ClassOfWarrantOrRightOutstanding | Class of Warrant or Right, Outstanding | shares | 4.50M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001493152-26-012925 | |
| us-gaap | CommonStockCapitalSharesReservedForFutureIssuance | Common Stock, Capital Shares Reserved for Future Issuance | shares | 12.88M | 2021-09-30 | 2022 | Q3 | 10-Q | 2022-11-14 | 0001493152-22-031668 | |
| us-gaap | CommonStockParOrStatedValuePerShare | Common Stock, Par or Stated Value Per Share | USD/shares | 0 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-14 | 0001493152-26-023126 | |
| us-gaap | CommonStockSharesAuthorized | Common Stock, Shares Authorized | shares | 75.00M | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-14 | 0001493152-26-023126 | |
| us-gaap | CommonStockSharesIssued | Common Stock, Shares, Issued | shares | 25.48M | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-14 | 0001493152-26-023126 | |
| us-gaap | CommonStockSharesOutstanding | Common Stock, Shares, Outstanding | shares | 25.48M | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-14 | 0001493152-26-023126 | |
| us-gaap | CommonStockSharesSubscriptions | Common Stock, Value, Subscriptions | USD | 23.00M | 2021-11-09 | 2022 | Q3 | 10-Q | 2022-11-14 | 0001493152-22-031668 | |
| us-gaap | CommonStockValue | Common Stock, Value, Issued | USD | 2,548 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-14 | 0001493152-26-023126 | |
| us-gaap | ContractWithCustomerLiabilityCurrent | Contract with Customer, Liability, Current | USD | 150,000 | 2025-03-31 | 2025 | Q1 | 10-Q | 2025-05-14 | 0001641172-25-010299 | |
| us-gaap | ConversionOfStockAmountConverted1 | Conversion of Stock, Amount Converted | USD | 80,000 | 2016-01-01 | 2016-09-30 | 2016 | Q3 | 10-Q | 2016-11-14 | 0001493152-16-015059 |
| us-gaap | ConvertibleNotesPayable | Convertible Notes Payable | USD | 3.00M | 2021-07-16 | 2021 | Q2 | 10-Q | 2021-08-16 | 0001493152-21-019979 | |
| us-gaap | CostOfGoodsAndServicesSold | Cost of Goods and Services Sold | USD | 7,385 | 2026-01-01 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-14 | 0001493152-26-023126 |
| us-gaap | CostOfGoodsSold | Cost of Goods Sold (Deprecated 2018-01-31) | USD | 102 | 2016-01-01 | 2016-12-31 | 2017 | FY | 10-K | 2018-04-02 | 0001493152-18-004554 |
| us-gaap | CurrentFederalTaxExpenseBenefit | Current Federal Tax Expense (Benefit) | USD | 0 | 2015-01-01 | 2015-12-31 | 2015 | FY | 10-K | 2016-03-30 | 0001144204-16-091575 |
| us-gaap | CurrentStateAndLocalTaxExpenseBenefit | Current State and Local Tax Expense (Benefit) | USD | 0 | 2015-01-01 | 2015-12-31 | 2015 | FY | 10-K | 2016-03-30 | 0001144204-16-091575 |
| us-gaap | DebtConversionConvertedInstrumentAmount1 | Debt Conversion, Converted Instrument, Amount | USD | 228,932 | 2021-01-01 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-15 | 0001493152-21-028733 |
| us-gaap | DebtConversionConvertedInstrumentSharesIssued1 | Debt Conversion, Converted Instrument, Shares Issued | shares | 6,250 | 2015-01-01 | 2015-12-31 | 2016 | FY | 10-K | 2017-03-22 | 0001493152-17-002701 |
| us-gaap | DebtConversionOriginalDebtAmount1 | Debt Conversion, Original Debt, Amount | USD | 1.56M | 2019-05-01 | 2019-08-31 | 2019 | Q3 | 10-Q | 2019-11-13 | 0001493152-19-017053 |
| us-gaap | DebtInstrumentAnnualPrincipalPayment | Debt Instrument, Annual Principal Payment | USD | 75,000 | 2015-12-31 | 2015 | FY | 10-K | 2016-03-30 | 0001144204-16-091575 | |
| us-gaap | DebtInstrumentCarryingAmount | Long-term Debt, Gross | USD | 5.89M | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-15 | 0001493152-21-028733 | |
| us-gaap | DebtInstrumentConvertibleBeneficialConversionFeature | Debt Instrument, Convertible, Beneficial Conversion Feature | USD | 14,103 | 2021-09-26 | 2021-09-27 | 2021 | FY | 10-K | 2022-03-30 | 0001493152-22-008184 |
| us-gaap | DebtInstrumentConvertibleConversionPrice1 | Debt Instrument, Convertible, Conversion Price | USD/shares | 0.1 | 2018-09-30 | 2018 | Q3 | 10-Q | 2018-11-13 | 0001493152-18-015801 | |
| us-gaap | DebtInstrumentDecreaseForgiveness | Debt Instrument, Decrease, Forgiveness | USD | 250,000 | 2022-01-01 | 2022-12-31 | 2023 | FY | 10-K/A | 2024-06-11 | 0001493152-24-023479 |
| us-gaap | DebtInstrumentFaceAmount | Debt Instrument, Face Amount | USD | 183,043 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-15 | 0001493152-21-028733 | |
| us-gaap | DebtInstrumentIncreaseAccruedInterest | Debt Instrument, Increase, Accrued Interest | USD | 35,000 | 2014-01-01 | 2014-09-30 | 2014 | Q3 | 10-Q | 2014-11-13 | 0001144204-14-067818 |
| us-gaap | DebtInstrumentIncreaseDecreaseOtherNet | Debt Instrument, Increase (Decrease), Other, Net | USD | 73,058 | 2014-01-01 | 2014-09-30 | 2014 | Q3 | 10-Q | 2014-11-13 | 0001144204-14-067818 |
| us-gaap | DebtInstrumentInterestRateDuringPeriod | Debt Instrument, Interest Rate During Period | pure | 0.15 | 2014-01-01 | 2014-12-31 | 2014 | FY | 10-K | 2015-03-31 | 0001144204-15-020255 |
| us-gaap | DebtInstrumentInterestRateEffectivePercentage | Debt Instrument, Interest Rate, Effective Percentage | pure | 0.79 | 2014-05-02 | 2014 | Q3 | 10-Q | 2014-11-13 | 0001144204-14-067818 | |
| us-gaap | DebtInstrumentInterestRateStatedPercentage | Debt Instrument, Interest Rate, Stated Percentage | pure | 0.166 | 2020-11-16 | 2021 | FY | 10-K | 2022-03-30 | 0001493152-22-008184 | |
| us-gaap | DebtInstrumentInterestRateStatedPercentageRateRangeMaximum | Debt Instrument, Interest Rate, Stated Percentage Rate Range, Maximum (Deprecated 2016-01-31) | pure | 0.15 | 2014-01-01 | 2014-09-30 | 2014 | Q3 | 10-Q | 2014-11-13 | 0001144204-14-067818 |
| us-gaap | DebtInstrumentInterestRateStatedPercentageRateRangeMinimum | Debt Instrument, Interest Rate, Stated Percentage Rate Range, Minimum (Deprecated 2016-01-31) | pure | 0.08 | 2014-01-01 | 2014-09-30 | 2014 | Q3 | 10-Q | 2014-11-13 | 0001144204-14-067818 |
| us-gaap | DebtInstrumentPeriodicPaymentInterest | Debt Instrument, Periodic Payment, Interest | USD | 23,013 | 2019-01-01 | 2019-12-31 | 2020 | FY | 10-K | 2021-04-30 | 0001493152-21-010062 |
| us-gaap | DebtInstrumentPeriodicPaymentPrincipal | Debt Instrument, Periodic Payment, Principal | USD | 25,000 | 2016-03-01 | 2016-03-04 | 2016 | Q1 | 10-Q | 2016-05-13 | 0001144204-16-101925 |
| us-gaap | DebtInstrumentUnamortizedDiscount | Debt Instrument, Unamortized Discount | USD | 0 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-30 | 0001493152-22-008184 | |
| us-gaap | DebtInstrumentUnamortizedDiscountCurrent | Debt Instrument, Unamortized Discount, Current | USD | 0 | 2020-12-31 | 2020 | FY | 10-K | 2021-04-30 | 0001493152-21-010062 | |
| us-gaap | DebtInstrumentUnamortizedDiscountNoncurrent | Debt Instrument, Unamortized Discount, Noncurrent | USD | 5.37M | 2020-12-31 | 2021 | FY | 10-K | 2022-03-30 | 0001493152-22-008184 | |
| us-gaap | DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction | Debt Issuance Costs Incurred During Noncash or Partial Noncash Transaction | USD | 333,117 | 2015-01-01 | 2015-09-30 | 2015 | Q3 | 10-Q | 2015-11-23 | 0001144204-15-067511 |
| us-gaap | DebtorInPossessionFinancingAmountArranged | Debtor-in-Possession Financing, Amount Arranged | USD | 1.19M | 2021-06-30 | 2021 | Q2 | 10-Q | 2021-08-16 | 0001493152-21-019979 | |
| us-gaap | DebtorReorganizationItemsLegalAndAdvisoryProfessionalFees | Debtor Reorganization Items, Legal and Advisory Professional Fees | USD | 476,652 | 2020-01-01 | 2020-12-31 | 2021 | FY | 10-K | 2022-03-30 | 0001493152-22-008184 |
| us-gaap | DebtorReorganizationItemsWriteOffOfDeferredFinancingCostsAndDebtDiscounts | Debtor Reorganization Items, Write-off of Debt Issuance Costs and Debt Discounts | USD | -2.58M | 2020-01-01 | 2020-12-31 | 2021 | FY | 10-K | 2022-03-30 | 0001493152-22-008184 |
| us-gaap | DeferredCosts | Deferred Costs, Noncurrent | USD | 9,517 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001493152-26-012925 | |
| us-gaap | DeferredFederalIncomeTaxExpenseBenefit | Deferred Federal Income Tax Expense (Benefit) | USD | 2.89M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001493152-26-012925 |
| us-gaap | DeferredFederalStateAndLocalTaxExpenseBenefit | Deferred Federal, State and Local, Tax Expense (Benefit) | USD | 6.85M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001493152-26-012925 |
| us-gaap | DeferredIncomeTaxLiabilities | Deferred Tax Liabilities, Gross | USD | 147,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001493152-26-012925 | |
| us-gaap | DeferredOfferingCosts | Deferred Offering Costs | USD | 0 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-14 | 0001493152-26-023126 | |
| us-gaap | DeferredRevenue | Deferred Revenue | USD | 80,700 | 2024-06-30 | 2024 | Q2 | 10-Q | 2024-08-13 | 0001493152-24-031636 | |
| us-gaap | DeferredRevenueCurrent | Deferred Revenue, Current | USD | 0 | 2015-12-31 | 2015 | FY | 10-K | 2016-03-30 | 0001144204-16-091575 | |
| us-gaap | DeferredRevenueRevenueRecognized | Deferred Revenue, Revenue Recognized (Deprecated 2016-01-31) | USD | 587,364 | 2015-01-01 | 2015-09-30 | 2015 | Q3 | 10-Q | 2015-11-23 | 0001144204-15-067511 |
| us-gaap | DeferredStateAndLocalIncomeTaxExpenseBenefit | Deferred State and Local Income Tax Expense (Benefit) | USD | 3.96M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001493152-26-012925 |
| us-gaap | DeferredTaxAssetsCharitableContributionCarryforwards | Deferred Tax Assets, Charitable Contribution Carryforwards | USD | 139,800 | 2013-12-31 | 2013 | FY | 10-K | 2014-04-11 | 0001144204-14-022141 | |
| us-gaap | DeferredTaxAssetsGoodwillAndIntangibleAssets | Deferred Tax Assets, Goodwill and Intangible Assets | USD | 0 | 2013-12-31 | 2013 | FY | 10-K | 2014-04-11 | 0001144204-14-022141 | |
| us-gaap | DeferredTaxAssetsGross | Deferred Tax Assets, Gross | USD | 22.73M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001493152-26-012925 | |
| us-gaap | DeferredTaxAssetsInProcessResearchAndDevelopment | Deferred Tax Assets, in Process Research and Development | USD | 1.39M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001493152-26-012925 | |
| us-gaap | DeferredTaxAssetsLiabilitiesNet | Deferred Tax Assets, Net | USD | 22.58M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001493152-26-012925 | |
| us-gaap | DeferredTaxAssetsNet | Deferred Tax Assets, Net of Valuation Allowance | USD | 0 | 2015-12-31 | 2015 | FY | 10-K | 2016-03-30 | 0001144204-16-091575 | |
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwards | Deferred Tax Assets, Operating Loss Carryforwards | USD | 19.53M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001493152-26-012925 | |
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration | Deferred Tax Assets, Operating Loss Carryforwards, Not Subject to Expiration | USD | 60.40M | 2024-12-31 | 2024 | FY | 10-K | 2025-03-28 | 0001641172-25-001011 | |
| us-gaap | DeferredTaxAssetsOther | Deferred Tax Assets, Other | USD | 600 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001493152-26-012925 | |
| us-gaap | DeferredTaxAssetsTaxCreditCarryforwardsResearch | Deferred Tax Assets, Tax Credit Carryforwards, Research | USD | 330,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001493152-26-012925 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Employee Compensation | USD | 188,800 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001493152-26-012925 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost | USD | 1.29M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001493152-26-012925 | |
| us-gaap | DeferredTaxAssetsValuationAllowance | Deferred Tax Assets, Valuation Allowance | USD | 22.58M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001493152-26-012925 | |
| us-gaap | DeferredTaxLiabilitiesGoodwillAndIntangibleAssets | Deferred Tax Liabilities, Goodwill and Intangible Assets | USD | 30,000 | 2020-12-31 | 2020 | FY | 10-K | 2021-04-30 | 0001493152-21-010062 | |
| us-gaap | DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets | Deferred Tax Liabilities, Intangible Assets | USD | 29,400 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001493152-26-012925 | |
| us-gaap | DeferredTaxLiabilitiesLeasingArrangements | Deferred Tax Liabilities, Leasing Arrangements | USD | 39,000 | 2023-12-31 | 2024 | FY | 10-K | 2025-03-28 | 0001641172-25-001011 | |
| us-gaap | DeferredTaxLiabilitiesOther | Deferred Tax Liabilities, Other | USD | 37,600 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001493152-26-012925 | |
| us-gaap | DepositsAssetsNoncurrent | Deposits Assets, Noncurrent | USD | 0 | 2012-12-31 | 2012 | FY | 10-K | 2013-04-02 | 0001144204-13-019421 | |
| us-gaap | Depreciation | Depreciation | USD | 120,238 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001493152-26-012925 |
| us-gaap | DepreciationAndAmortization | Depreciation, Depletion and Amortization, Nonproduction | USD | 52,394 | 2026-01-01 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-14 | 0001493152-26-023126 |
| us-gaap | DepreciationDepletionAndAmortization | Depreciation, Depletion and Amortization | USD | 80,877 | 2023-01-01 | 2023-06-30 | 2023 | Q2 | 10-Q | 2023-08-11 | 0001493152-23-027825 |
| us-gaap | DerivativeGainLossOnDerivativeNet | Derivative, Gain (Loss) on Derivative, Net | USD | 1.22M | 2026-01-01 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-14 | 0001493152-26-023126 |
| us-gaap | DerivativeInstrumentsAndHedgesLiabilities | Derivative Instruments and Hedges, Liabilities | USD | 1.54M | 2023-12-31 | 2023 | FY | 10-K/A | 2024-06-11 | 0001493152-24-023479 | |
| us-gaap | DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet | Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net | USD | 4.00M | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K/A | 2024-06-11 | 0001493152-24-023479 |
| us-gaap | DerivativeLiabilities | Derivative Liability | USD | 2.19M | 2024-02-08 | 2025 | FY | 10-K | 2026-03-26 | 0001493152-26-012925 | |
| us-gaap | DerivativeLiabilitiesCurrent | Derivative Liability, Current | USD | 1.40M | 2025-12-31 | 2026 | Q1 | 10-Q | 2026-05-14 | 0001493152-26-023126 | |
| us-gaap | DerivativeLossOnDerivative | Derivative, Loss on Derivative | USD | 1.87M | 2024-01-01 | 2024-06-30 | 2024 | Q2 | 10-Q | 2024-08-13 | 0001493152-24-031636 |
| us-gaap | DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage | Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) | USD | 23.92M | 2014-09-30 | 2014 | Q3 | 10-Q | 2014-11-13 | 0001144204-14-067818 | |
| us-gaap | DilutiveSecurities | Dilutive Securities, Effect on Basic Earnings Per Share | USD | 8.33M | 2013-01-01 | 2013-06-30 | 2013 | Q2 | 10-Q | 2013-08-19 | 0001144204-13-046897 |
| us-gaap | DueToOfficersOrStockholdersCurrent | Due to Officers or Stockholders, Current | USD | 68,000 | 2015-06-30 | 2015 | Q2 | 10-Q | 2015-08-14 | 0001144204-15-049960 | |
| us-gaap | DueToRelatedPartiesCurrent | Due to Related Parties, Current | USD | 87,030 | 2015-12-31 | 2016 | FY | 10-K | 2017-03-22 | 0001493152-17-002701 | |
| us-gaap | EarningsPerShareBasic | Earnings Per Share, Basic | USD/shares | -0.12 | 2026-01-01 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-14 | 0001493152-26-023126 |
| us-gaap | EarningsPerShareBasicAndDiluted | Earnings Per Share, Basic and Diluted | USD/shares | -37.3 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-30 | 0001493152-22-008184 |
| us-gaap | EarningsPerShareDiluted | Earnings Per Share, Diluted | USD/shares | -0.12 | 2026-01-01 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-14 | 0001493152-26-023126 |
| us-gaap | EffectiveIncomeTaxRateContinuingOperations | Effective Income Tax Rate Reconciliation, Percent | pure | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001493152-26-012925 |
| us-gaap | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent | pure | 0.21 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001493152-26-012925 |
| us-gaap | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent | pure | 0.204 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001493152-26-012925 |
| us-gaap | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent | pure | 0 | 2018-01-01 | 2018-12-31 | 2018 | FY | 10-K | 2019-03-29 | 0001493152-19-004292 |
| us-gaap | EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectPercent | EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectPercent | pure | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001493152-26-012925 |
| us-gaap | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent | pure | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001493152-26-012925 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent | pure | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001493152-26-012925 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent | pure | -0.434 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001493152-26-012925 |
| us-gaap | EffectiveIncomeTaxRateReconciliationOtherAdjustments | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent | pure | 0.004 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001493152-26-012925 |
| us-gaap | EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes | Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Percent | pure | 1 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-28 | 0001641172-25-001011 |
| us-gaap | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Percent | pure | -0.621 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001493152-26-012925 |
| us-gaap | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent | pure | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001493152-26-012925 |
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxCredits | Effective Income Tax Rate Reconciliation, Tax Credit, Percent | pure | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001493152-26-012925 |
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxCreditsOther | Effective Income Tax Rate Reconciliation, Tax Credit, Other, Percent | pure | 0 | 2018-01-01 | 2018-12-31 | 2018 | FY | 10-K | 2019-03-29 | 0001493152-19-004292 |
| us-gaap | EmployeeBenefitsAndShareBasedCompensation | Employee Benefits and Share-based Compensation | USD | 6.00M | 2022-01-01 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-14 | 0001493152-22-031668 |
| us-gaap | EmployeeRelatedLiabilitiesCurrent | Employee-related Liabilities, Current | USD | 746,000 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-14 | 0001493152-26-023126 | |
| us-gaap | EmployeeRelatedLiabilitiesCurrentAndNoncurrent | Employee-related Liabilities | USD | 704,000 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-28 | 0001641172-25-001011 | |
| us-gaap | EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized | Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount | USD | 1.06M | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-12 | 0001493152-24-044763 | |
| us-gaap | EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions | Share-based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount | USD | 1.18M | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-14 | 0001493152-26-023126 | |
| us-gaap | EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions | Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount | USD | 10.80M | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-14 | 0001493152-22-031668 | |
| us-gaap | EntityWideRevenueMajorCustomerPercentage | Entity-Wide Revenue, Major Customer, Percentage (Deprecated 2013-01-31) | pure | 1 | 2012-01-01 | 2012-06-30 | 2012 | Q2 | 10-Q | 2012-08-14 | 0001144204-12-045890 |
| us-gaap | ExtinguishmentOfDebtAmount | Extinguishment of Debt, Amount | USD | 141,818 | 2019-01-01 | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-11-13 | 0001493152-19-017053 |
| us-gaap | FairValueAdjustmentOfWarrants | Fair Value Adjustment of Warrants | USD | 1.22M | 2026-01-01 | 2026-02-24 | 2026 | Q1 | 10-Q | 2026-05-14 | 0001493152-26-023126 |
| us-gaap | FairValueAssumptionsExpectedDividendRate | Fair Value Assumptions, Expected Dividend Rate (Deprecated 2018-01-31) | pure | 0 | 2017-09-29 | 2017-09-30 | 2017 | Q3 | 10-Q | 2017-11-14 | 0001493152-17-013246 |
| us-gaap | FairValueAssumptionsExpectedVolatilityRate | Fair Value Assumptions, Expected Volatility Rate (Deprecated 2018-01-31) | pure | 1.11 | 2017-09-29 | 2017-09-30 | 2017 | Q3 | 10-Q | 2017-11-14 | 0001493152-17-013246 |
| us-gaap | FairValueAssumptionsRiskFreeInterestRate | Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) | pure | 0.013 | 2017-09-29 | 2017-09-30 | 2017 | Q3 | 10-Q | 2017-11-14 | 0001493152-17-013246 |
| us-gaap | FiniteLivedIntangibleAssetsAccumulatedAmortization | Finite-Lived Intangible Assets, Accumulated Amortization | USD | 696,804 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-15 | 0001493152-21-028733 | |
| us-gaap | FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive | Finite-Lived Intangible Asset, Expected Amortization, after Year Five | USD | 167,434 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001493152-26-012925 | |
| us-gaap | FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths | Finite-Lived Intangible Asset, Expected Amortization, Year One | USD | 89,747 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001493152-26-012925 | |
| us-gaap | FiniteLivedIntangibleAssetsAmortizationExpenseYearFive | Finite-Lived Intangible Asset, Expected Amortization, Year Five | USD | 14,603 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001493152-26-012925 | |
| us-gaap | FiniteLivedIntangibleAssetsAmortizationExpenseYearFour | Finite-Lived Intangible Asset, Expected Amortization, Year Four | USD | 82,920 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001493152-26-012925 | |
| us-gaap | FiniteLivedIntangibleAssetsAmortizationExpenseYearThree | Finite-Lived Intangible Asset, Expected Amortization, Year Three | USD | 89,747 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001493152-26-012925 | |
| us-gaap | FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo | Finite-Lived Intangible Asset, Expected Amortization, Year Two | USD | 89,747 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001493152-26-012925 | |
| us-gaap | FiniteLivedIntangibleAssetsNet | Finite-Lived Intangible Assets, Net | USD | 534,198 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001493152-26-012925 | |
| us-gaap | FurnitureAndFixturesGross | Furniture and Fixtures, Gross | USD | 126,150 | 2015-12-31 | 2015 | FY | 10-K | 2016-03-30 | 0001144204-16-091575 | |
| us-gaap | GainLossOnSaleOfPropertyPlantEquipment | Gain (Loss) on Disposition of Property Plant Equipment | USD | 39,476 | 2016-01-01 | 2016-12-31 | 2016 | FY | 10-K | 2017-03-22 | 0001493152-17-002701 |
| us-gaap | GainLossRelatedToLitigationSettlement | Gain (Loss) Related to Litigation Settlement | USD | 3,970 | 2012-10-01 | 2012-10-18 | 2013 | FY | 10-K | 2014-04-11 | 0001144204-14-022141 |
| us-gaap | GainsLossesOnExtinguishmentOfDebt | Gain (Loss) on Extinguishment of Debt | USD | -16.18M | 2021-01-01 | 2021-12-31 | 2022 | FY | 10-K | 2023-03-27 | 0001493152-23-008960 |
| us-gaap | GeneralAndAdministrativeExpense | General and Administrative Expense | USD | 1.48M | 2026-01-01 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-14 | 0001493152-26-023126 |
| us-gaap | GrossProfit | Gross Profit | USD | 15,785 | 2026-01-01 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-14 | 0001493152-26-023126 |
| us-gaap | ImpairmentOfLongLivedAssetsToBeDisposedOf | Impairment of Long-Lived Assets to be Disposed of | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001493152-26-012925 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic | Income (Loss) from Continuing Operations before Income Taxes, Domestic | USD | -14.20M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001493152-26-012925 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | USD | -14.20M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001493152-26-012925 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign | Income (Loss) from Continuing Operations before Income Taxes, Foreign | USD | -8,912 | 2016-01-01 | 2016-12-31 | 2017 | FY | 10-K | 2018-04-02 | 0001493152-18-004554 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments | Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest | USD | -9.44M | 2017-01-01 | 2017-12-31 | 2017 | FY | 10-K | 2018-04-02 | 0001493152-18-004554 |
| us-gaap | IncomeTaxExpenseBenefit | Income Tax Expense (Benefit) | USD | 0 | 2015-01-01 | 2015-12-31 | 2015 | FY | 10-K | 2016-03-30 | 0001144204-16-091575 |
| us-gaap | IncomeTaxExpenseBenefitContinuingOperations | Income Tax Expense (Benefit), Continuing Operations (Deprecated 2013-01-31) | USD | 0 | 2012-01-01 | 2012-12-31 | 2012 | FY | 10-K | 2013-04-02 | 0001144204-13-019421 |
| us-gaap | IncomeTaxExpenseBenefitContinuingOperationsDiscontinuedOperationsExtraordinaryItems | Income Tax Expense (Benefit), Continuing Operations, Discontinued Operations | USD | 0 | 2013-01-01 | 2013-12-31 | 2013 | FY | 10-K | 2014-04-11 | 0001144204-14-022141 |
| us-gaap | IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount | USD | -2.89M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001493152-26-012925 |
| us-gaap | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount | USD | -2.98M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001493152-26-012925 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpenseOther | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount | USD | 2,100 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001493152-26-012925 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount | USD | 6.16M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001493152-26-012925 |
| us-gaap | IncomeTaxReconciliationOtherAdjustments | Effective Income Tax Rate Reconciliation, Other Adjustments, Amount | USD | -52,100 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001493152-26-012925 |
| us-gaap | IncreaseDecreaseInAccountsPayable | Increase (Decrease) in Accounts Payable | USD | -682,003 | 2026-01-01 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-14 | 0001493152-26-023126 |
| us-gaap | IncreaseDecreaseInAccountsReceivable | Increase (Decrease) in Accounts Receivable | USD | -2,200 | 2026-01-01 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-14 | 0001493152-26-023126 |
| us-gaap | IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities | USD | -64,070 | 2026-01-01 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-14 | 0001493152-26-023126 |
| us-gaap | IncreaseDecreaseInContractWithCustomerLiability | Increase (Decrease) in Contract with Customer, Liability | USD | 80,700 | 2024-01-01 | 2024-06-30 | 2025 | Q2 | 10-Q | 2025-08-12 | 0001641172-25-023211 |
| us-gaap | IncreaseDecreaseInDeferredRevenue | Increase (Decrease) in Deferred Revenue | USD | 150,000 | 2025-01-01 | 2025-03-31 | 2026 | Q1 | 10-Q | 2026-05-14 | 0001493152-26-023126 |
| us-gaap | IncreaseDecreaseInDepositOtherAssets | Increase (Decrease) in Deposit Assets | USD | 0 | 2016-01-01 | 2016-03-31 | 2016 | Q1 | 10-Q | 2016-05-13 | 0001144204-16-101925 |
| us-gaap | IncreaseDecreaseInDeposits | Increase (Decrease) in Deposits | USD | -4,415 | 2008-12-30 | 2011-06-30 | 2011 | Q2 | 10-Q/A | 2011-09-14 | 0001144204-11-053024 |
| us-gaap | IncreaseDecreaseInDerivativeLiabilities | Increase (Decrease) in Derivative Liabilities | USD | -3.48M | 2023-01-01 | 2023-09-30 | 2023 | FY | 10-K/A | 2024-06-11 | 0001493152-24-023479 |
| us-gaap | IncreaseDecreaseInFinanceReceivables | Increase (Decrease) in Finance Receivables | USD | 2.00M | 2012-03-03 | 2012-04-02 | 2013 | FY | 10-K | 2014-04-11 | 0001144204-14-022141 |
| us-gaap | IncreaseDecreaseInInterestPayableNet | Increase (Decrease) in Interest Payable, Net | USD | 120,552 | 2016-01-01 | 2016-12-31 | 2016 | FY | 10-K | 2017-03-22 | 0001493152-17-002701 |
| us-gaap | IncreaseDecreaseInInventories | Increase (Decrease) in Inventories | USD | 547 | 2015-01-01 | 2015-09-30 | 2016 | Q3 | 10-Q | 2016-11-14 | 0001493152-16-015059 |
| us-gaap | IncreaseDecreaseInOperatingLeaseLiability | IncreaseDecreaseInOperatingLeaseLiability | USD | -162,317 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001493152-26-012925 |
| us-gaap | IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets | Increase (Decrease) in Prepaid Expense and Other Assets | USD | 25,938 | 2026-01-01 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-14 | 0001493152-26-023126 |
| us-gaap | IncreaseDecreaseInSecurityDeposits | Increase (Decrease) in Security Deposits | USD | 22,100 | 2019-01-01 | 2019-12-31 | 2020 | FY | 10-K | 2021-04-30 | 0001493152-21-010062 |
| us-gaap | IntangibleAssetsNetExcludingGoodwill | Intangible Assets, Net (Excluding Goodwill) | USD | 511,761 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-14 | 0001493152-26-023126 | |
| us-gaap | InterestAndDividendIncomeOperating | Interest and Dividend Income, Operating | USD | 6,064 | 2026-01-01 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-14 | 0001493152-26-023126 |
| us-gaap | InterestAndDividendIncomeSecuritiesHeldToMaturity | Interest Income, Debt Securities, Held-to-maturity | USD | 5,479 | 2026-01-01 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-14 | 0001493152-26-023126 |
| us-gaap | InterestExpense | Interest Expense | USD | 104,465 | 2022-01-01 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-14 | 0001493152-22-031668 |
| us-gaap | InterestExpenseDebt | Interest Expense, Debt | USD | 6,769 | 2021-01-01 | 2021-06-30 | 2021 | Q2 | 10-Q | 2021-08-16 | 0001493152-21-019979 |
| us-gaap | InterestExpenseOther | Interest Expense, Other | USD | 75,624 | 2022-01-01 | 2022-06-30 | 2022 | Q2 | 10-Q | 2022-08-15 | 0001493152-22-022617 |
| us-gaap | InterestIncomeExpenseNet | Interest Income (Expense), Net | USD | 266,207 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001493152-26-012925 |
| us-gaap | InterestPaid | Interest Paid, Including Capitalized Interest, Operating and Investing Activities | USD | 11,000 | 2017-01-01 | 2017-06-30 | 2017 | Q2 | 10-Q | 2017-08-14 | 0001493152-17-009275 |
| us-gaap | InterestPaidNet | Interest Paid, Excluding Capitalized Interest, Operating Activities | USD | 983 | 2026-01-01 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-14 | 0001493152-26-023126 |
| us-gaap | InterestPayableCurrent | Interest Payable, Current | USD | 532,005 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-15 | 0001493152-21-028733 | |
| us-gaap | InterestPayableCurrentAndNoncurrent | Interest Payable | USD | 54,159 | 2021-11-09 | 2021 | FY | 10-K | 2022-03-30 | 0001493152-22-008184 | |
| us-gaap | InventoryNet | Inventory, Net | USD | 2,492 | 2015-09-30 | 2015 | Q3 | 10-Q | 2015-11-23 | 0001144204-15-067511 | |
| us-gaap | InventoryWriteDown | Inventory Write-down | USD | 0 | 2015-01-01 | 2015-12-31 | 2015 | FY | 10-K | 2016-03-30 | 0001144204-16-091575 |
| us-gaap | IssuanceOfStockAndWarrantsForServicesOrClaims | Issuance of Stock and Warrants for Services or Claims | USD | 112,847 | 2015-01-01 | 2015-12-31 | 2015 | FY | 10-K | 2016-03-30 | 0001144204-16-091575 |
| us-gaap | LaborAndRelatedExpense | Labor and Related Expense | USD | 4.12M | 2008-12-30 | 2012-12-31 | 2012 | FY | 10-K | 2013-04-02 | 0001144204-13-019421 |
| us-gaap | LeaseAndRentalExpense | Operating Leases, Rent Expense | USD | 74,000 | 2019-01-01 | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-11-13 | 0001493152-19-017053 |
| us-gaap | LeaseCost | Lease, Cost | USD | 174,352 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001493152-26-012925 |
| us-gaap | LeaseholdImprovementsGross | Leasehold Improvements, Gross | USD | 301,610 | 2015-12-31 | 2015 | FY | 10-K | 2016-03-30 | 0001144204-16-091575 | |
| us-gaap | LegalFees | Legal Fees | USD | 100,000 | 2012-01-01 | 2012-12-31 | 2012 | FY | 10-K | 2013-04-02 | 0001144204-13-019421 |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDue | Lessee, Operating Lease, Liability, to be Paid | USD | 43,265 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-12 | 0001493152-24-044763 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths | Lessee, Operating Lease, Liability, to be Paid, Year One | USD | 173,060 | 2023-12-31 | 2023 | FY | 10-K/A | 2024-06-11 | 0001493152-24-023479 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearFive | Lessee, Operating Lease, Liability, to be Paid, Year Five | USD | 173,060 | 2019-12-31 | 2019 | FY | 10-K | 2021-03-18 | 0001493152-21-006285 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearFour | Lessee, Operating Lease, Liability, to be Paid, Year Four | USD | 173,060 | 2020-12-31 | 2020 | FY | 10-K | 2021-04-30 | 0001493152-21-010062 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearThree | Lessee, Operating Lease, Liability, to be Paid, Year Three | USD | 173,060 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-30 | 0001493152-22-008184 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearTwo | Lessee, Operating Lease, Liability, to be Paid, Year Two | USD | 173,060 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-27 | 0001493152-23-008960 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear | Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year | USD | 43,265 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-12 | 0001493152-24-044763 | |
| us-gaap | LesseeOperatingLeaseLiabilityUndiscountedExcessAmount | Lessee, Operating Lease, Liability, Undiscounted Excess Amount | USD | 851 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-12 | 0001493152-24-044763 | |
| us-gaap | Liabilities | Liabilities | USD | 3.67M | 2025-06-30 | 2025 | Q2 | 10-Q | 2025-08-12 | 0001641172-25-023211 | |
| us-gaap | LiabilitiesAndStockholdersEquity | Liabilities and Equity | USD | 4.64M | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-14 | 0001493152-26-023126 | |
| us-gaap | LiabilitiesCurrent | Liabilities, Current | USD | 1.61M | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-14 | 0001493152-26-023126 | |
| us-gaap | LiabilitiesFairValueDisclosure | Financial and Nonfinancial Liabilities, Fair Value Disclosure | USD | 1.97M | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-11-12 | 0001493152-25-021993 | |
| us-gaap | LiabilitiesSubjectToCompromise | Liabilities Subject to Compromise | USD | 14.70M | 2020-09-30 | 2020 | Q3 | 10-Q | 2021-04-12 | 0001493152-21-008499 | |
| us-gaap | LiabilitiesSubjectToCompromiseAccountsPayableAndAccruedLiabilities | Liabilities Subject to Compromise, Accounts Payable and Accrued Liabilities | USD | 2.13M | 2020-09-30 | 2020 | Q3 | 10-Q | 2021-04-12 | 0001493152-21-008499 | |
| us-gaap | LiabilitiesSubjectToCompromiseDebtAndAccruedInterest | Liabilities Subject to Compromise, Debt and Accrued Interest | USD | 1.03M | 2020-09-30 | 2020 | Q3 | 10-Q | 2021-04-12 | 0001493152-21-008499 | |
| us-gaap | LitigationSettlementExpense | Litigation Settlement, Expense | USD | 21,000 | 2021-01-01 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-15 | 0001493152-21-028733 |
| us-gaap | LoansPayable | Loans Payable | USD | 250,000 | 2021-12-31 | 2023 | FY | 10-K/A | 2024-06-11 | 0001493152-24-023479 | |
| us-gaap | LoansPayableCurrent | Loans Payable, Current | USD | 58,970 | 2021-12-31 | 2022 | FY | 10-K | 2023-03-27 | 0001493152-23-008960 | |
| us-gaap | LongTermDebt | Long-term Debt | USD | 250,000 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-30 | 0001493152-22-008184 | |
| us-gaap | LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive | Long-Term Debt, Maturity, after Year Five | USD | 71,307 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-30 | 0001493152-22-008184 | |
| us-gaap | LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths | Long-Term Debt, Maturity, Year One | USD | 58,970 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-30 | 0001493152-22-008184 | |
| us-gaap | LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree | Long-Term Debt, Maturity, Year Three | USD | 60,161 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-30 | 0001493152-22-008184 | |
| us-gaap | LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo | Long-Term Debt, Maturity, Year Two | USD | 59,562 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-30 | 0001493152-22-008184 | |
| us-gaap | LongTermDebtNoncurrent | Long-term Debt, Excluding Current Maturities | USD | 196,876 | 2010-12-31 | 2011 | FY | 10-K | 2012-04-16 | 0001144204-12-021914 | |
| us-gaap | LongTermLoansPayable | Loans Payable, Noncurrent | USD | 191,030 | 2021-12-31 | 2022 | FY | 10-K | 2023-03-27 | 0001493152-23-008960 | |
| us-gaap | LongTermNotesPayable | Notes Payable, Noncurrent | USD | 4.27M | 2020-12-31 | 2021 | FY | 10-K | 2022-03-30 | 0001493152-22-008184 | |
| us-gaap | LossContingencyDamagesPaidValue | Loss Contingency, Damages Paid, Value | USD | 193,000 | 2013-11-01 | 2013-11-30 | 2014 | FY | 10-K | 2015-03-31 | 0001144204-15-020255 |
| us-gaap | LossContingencyDamagesSoughtValue | Loss Contingency, Damages Sought, Value | USD | 18,970 | 2012-10-01 | 2012-10-18 | 2013 | FY | 10-K | 2014-04-11 | 0001144204-14-022141 |
| us-gaap | MarketableSecurities | Marketable Securities | USD | 479,351 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-14 | 0001493152-26-023126 | |
| us-gaap | MarketableSecuritiesCurrent | Marketable Securities, Current | USD | 479,351 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-14 | 0001493152-26-023126 | |
| us-gaap | MarketableSecuritiesUnrealizedGainLoss | Marketable Securities, Unrealized Gain (Loss) | USD | -18,598 | 2023-01-01 | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-13 | 0001493152-23-040483 |
| us-gaap | MarketingAndAdvertisingExpense | Marketing and Advertising Expense | USD | 714 | 2022-01-01 | 2022-06-30 | 2022 | Q2 | 10-Q | 2022-08-15 | 0001493152-22-022617 |
| us-gaap | NetCashProvidedByUsedInFinancingActivities | Net Cash Provided by (Used in) Financing Activities | USD | 4.44M | 2026-01-01 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-14 | 0001493152-26-023126 |
| us-gaap | NetCashProvidedByUsedInFinancingActivitiesContinuingOperations | Net Cash Provided by (Used in) Financing Activities, Continuing Operations | USD | 715,085 | 2018-01-01 | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-15 | 0001493152-18-007130 |
| us-gaap | NetCashProvidedByUsedInInvestingActivities | Net Cash Provided by (Used in) Investing Activities | USD | 968,447 | 2026-01-01 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-14 | 0001493152-26-023126 |
| us-gaap | NetCashProvidedByUsedInInvestingActivitiesContinuingOperations | Net Cash Provided by (Used in) Investing Activities, Continuing Operations | USD | -3,617 | 2017-01-01 | 2017-12-31 | 2017 | FY | 10-K | 2018-04-02 | 0001493152-18-004554 |
| us-gaap | NetCashProvidedByUsedInOperatingActivities | Net Cash Provided by (Used in) Operating Activities | USD | -3.81M | 2026-01-01 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-14 | 0001493152-26-023126 |
| us-gaap | NetCashProvidedByUsedInOperatingActivitiesContinuingOperations | Net Cash Provided by (Used in) Operating Activities, Continuing Operations | USD | -1.16M | 2018-01-01 | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-15 | 0001493152-18-007130 |
| us-gaap | NetIncomeLoss | Net Income (Loss) Attributable to Parent | USD | -2.15M | 2026-01-01 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-14 | 0001493152-26-023126 |
| us-gaap | NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1 | Noncash or Part Noncash Acquisition, Fixed Assets Acquired | USD | 291,055 | 2008-12-30 | 2014-03-31 | 2014 | Q1 | 10-Q | 2014-05-14 | 0001144204-14-030532 |
| us-gaap | NonoperatingIncomeExpense | Nonoperating Income (Expense) | USD | 1.23M | 2026-01-01 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-14 | 0001493152-26-023126 |
| us-gaap | NotesPayable | Notes Payable | USD | 250,000 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-30 | 0001493152-22-008184 | |
| us-gaap | NotesPayableCurrent | Notes Payable, Current | USD | 58,970 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-30 | 0001493152-22-008184 | |
| us-gaap | NumberOfOperatingSegments | Number of Operating Segments | Segment | 1 | 2025-01-01 | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-11-12 | 0001493152-25-021993 |
| us-gaap | NumberOfReportableSegments | Number of Reportable Segments | Segment | 1 | 2025-01-01 | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-11-12 | 0001493152-25-021993 |
| us-gaap | OperatingExpenses | Operating Expenses | USD | 3.40M | 2026-01-01 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-14 | 0001493152-26-023126 |
| us-gaap | OperatingIncomeLoss | Operating Income (Loss) | USD | -3.39M | 2026-01-01 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-14 | 0001493152-26-023126 |
| us-gaap | OperatingLeaseCost | Operating Lease, Cost | USD | 174,352 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001493152-26-012925 |
| us-gaap | OperatingLeaseLiability | Operating Lease, Liability | USD | 42,414 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-12 | 0001493152-24-044763 | |
| us-gaap | OperatingLeaseLiabilityCurrent | Operating Lease, Liability, Current | USD | 162,317 | 2023-12-31 | 2024 | FY | 10-K | 2025-03-28 | 0001641172-25-001011 | |
| us-gaap | OperatingLeaseLiabilityNoncurrent | Operating Lease, Liability, Noncurrent | USD | 42,414 | 2023-09-30 | 2024 | Q3 | 10-Q | 2024-11-12 | 0001493152-24-044763 | |
| us-gaap | OperatingLeasePayments | Operating Lease, Payments | USD | 174,352 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001493152-26-012925 |
| us-gaap | OperatingLeaseRightOfUseAsset | Operating Lease, Right-of-Use Asset | USD | 151,447 | 2023-12-31 | 2024 | FY | 10-K | 2025-03-28 | 0001641172-25-001011 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDue | Operating Leases, Future Minimum Payments Due | USD | 184,572 | 2018-12-31 | 2018 | FY | 10-K | 2019-03-29 | 0001493152-19-004292 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueCurrent | Operating Leases, Future Minimum Payments Due, Next Twelve Months | USD | 147,257 | 2018-12-31 | 2018 | FY | 10-K | 2019-03-29 | 0001493152-19-004292 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInFourYears | Operating Leases, Future Minimum Payments, Due in Four Years | USD | 37,315 | 2016-12-31 | 2016 | FY | 10-K | 2017-03-22 | 0001493152-17-002701 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInThreeYears | Operating Leases, Future Minimum Payments, Due in Three Years | USD | 37,315 | 2017-12-31 | 2017 | FY | 10-K | 2018-04-02 | 0001493152-18-004554 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInTwoYears | Operating Leases, Future Minimum Payments, Due in Two Years | USD | 37,315 | 2018-12-31 | 2018 | FY | 10-K | 2019-03-29 | 0001493152-19-004292 | |
| us-gaap | OperatingLeasesRentExpenseNet | Operating Leases, Rent Expense, Net | USD | 97,000 | 2015-01-01 | 2015-09-30 | 2015 | Q3 | 10-Q | 2015-11-23 | 0001144204-15-067511 |
| us-gaap | OperatingLeaseWeightedAverageDiscountRatePercent | Operating Lease, Weighted Average Discount Rate, Percent | pure | 0.12 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001493152-26-012925 | |
| us-gaap | OperatingLossCarryforwards | Operating Loss Carryforwards | USD | 59.90M | 2022-12-31 | 2022 | FY | 10-K | 2023-03-27 | 0001493152-23-008960 | |
| us-gaap | OtherAccruedLiabilitiesCurrent | Other Accrued Liabilities, Current | USD | 947,739 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-14 | 0001493152-26-023126 | |
| us-gaap | OtherAccruedLiabilitiesCurrentAndNoncurrent | Other Accrued Liabilities | USD | 657,598 | 2020-12-31 | 2021 | FY | 10-K | 2022-03-30 | 0001493152-22-008184 | |
| us-gaap | OtherAccruedLiabilitiesNoncurrent | Other Accrued Liabilities, Noncurrent | USD | 14,345 | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-11-13 | 0001493152-19-017053 | |
| us-gaap | OtherLiabilitiesCurrent | Other Liabilities, Current | USD | 262,894 | 2017-09-30 | 2017 | Q3 | 10-Q | 2017-11-14 | 0001493152-17-013246 | |
| us-gaap | OtherNonoperatingExpense | Other Nonoperating Expense | USD | 17,284 | 2022-01-01 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-14 | 0001493152-22-031668 |
| us-gaap | OtherNonoperatingIncome | Other Nonoperating Income | USD | 29,300 | 2019-01-01 | 2019-12-31 | 2020 | FY | 10-K | 2021-04-30 | 0001493152-21-010062 |
| us-gaap | OtherNonoperatingIncomeExpense | Other Nonoperating Income (Expense) | USD | 5,728 | 2026-01-01 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-14 | 0001493152-26-023126 |
| us-gaap | OtherNotesPayable | Other Notes Payable | USD | 392,685 | 2014-09-30 | 2014 | Q3 | 10-Q | 2014-11-13 | 0001144204-14-067818 | |
| us-gaap | OtherPrepaidExpenseCurrent | Other Prepaid Expense, Current | USD | 540,280 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-16 | 0001493152-22-013396 | |
| us-gaap | OtherResearchAndDevelopmentExpense | Other Research and Development Expense | USD | 89,063 | 2014-01-01 | 2014-09-30 | 2014 | Q3 | 10-Q | 2014-11-13 | 0001144204-14-067818 |
| us-gaap | OtherSignificantNoncashTransactionValueOfConsiderationGiven1 | Other Significant Noncash Transaction, Value of Consideration Given | USD | 226,500 | 2008-12-30 | 2014-03-31 | 2014 | Q1 | 10-Q | 2014-05-14 | 0001144204-14-030532 |
| us-gaap | PaymentOfFinancingAndStockIssuanceCosts | Payment of Financing and Stock Issuance Costs | USD | 14,428 | 2019-01-01 | 2019-09-30 | 2020 | Q3 | 10-Q | 2021-04-12 | 0001493152-21-008499 |
| us-gaap | PaymentsForRepurchaseOfCommonStock | Payments for Repurchase of Common Stock | USD | 0 | 2026-01-01 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-14 | 0001493152-26-023126 |
| us-gaap | PaymentsForRoyalties | Payments for Royalties | USD | 100,000 | 2014-01-01 | 2014-12-31 | 2014 | FY | 10-K | 2015-03-31 | 0001144204-15-020255 |
| us-gaap | PaymentsOfDebtIssuanceCosts | Payments of Debt Issuance Costs | USD | 395,715 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001493152-26-012925 |
| us-gaap | PaymentsOfFinancingCosts | Payments of Financing Costs | USD | 500,000 | 2020-01-01 | 2020-12-31 | 2021 | FY | 10-K | 2022-03-30 | 0001493152-22-008184 |
| us-gaap | PaymentsOfStockIssuanceCosts | Payments of Stock Issuance Costs | USD | 559,164 | 2026-01-01 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-14 | 0001493152-26-023126 |
| us-gaap | PaymentsToAcquireIntangibleAssets | Payments to Acquire Intangible Assets | USD | 175,000 | 2022-01-01 | 2022-12-31 | 2023 | FY | 10-K/A | 2024-06-11 | 0001493152-24-023479 |
| us-gaap | PaymentsToAcquireMarketableSecurities | Payments to Acquire Marketable Securities | USD | 74,920 | 2026-01-01 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-14 | 0001493152-26-023126 |
| us-gaap | PaymentsToAcquireProductiveAssets | Payments to Acquire Productive Assets | USD | 222,642 | 2022-01-01 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-14 | 0001493152-22-031668 |
| us-gaap | PaymentsToAcquirePropertyPlantAndEquipment | Payments to Acquire Property, Plant, and Equipment | USD | 36,400 | 2025-01-01 | 2025-03-31 | 2026 | Q1 | 10-Q | 2026-05-14 | 0001493152-26-023126 |
| us-gaap | PreferredStockParOrStatedValuePerShare | Preferred Stock, Par or Stated Value Per Share | USD/shares | 0.01 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-14 | 0001493152-26-023126 | |
| us-gaap | PreferredStockSharesAuthorized | Preferred Stock, Shares Authorized | shares | 20.00M | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-14 | 0001493152-26-023126 | |
| us-gaap | PreferredStockSharesIssued | Preferred Stock, Shares Issued | shares | 0 | 2021-06-30 | 2021 | Q2 | 10-Q | 2021-08-16 | 0001493152-21-019979 | |
| us-gaap | PreferredStockSharesOutstanding | Preferred Stock, Shares Outstanding | shares | 0 | 2021-06-30 | 2021 | Q2 | 10-Q | 2021-08-16 | 0001493152-21-019979 | |
| us-gaap | PreferredStockValue | Preferred Stock, Value, Issued | USD | 13,982 | 2025-12-31 | 2026 | Q1 | 10-Q | 2026-05-14 | 0001493152-26-023126 | |
| us-gaap | PrepaidExpenseAndOtherAssetsCurrent | Prepaid Expense and Other Assets, Current | USD | 194,378 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-14 | 0001493152-26-023126 | |
| us-gaap | PrepaidExpenseCurrent | Prepaid Expense, Current | USD | 436,181 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-30 | 0001493152-22-008184 | |
| us-gaap | ProceedsFromConvertibleDebt | Proceeds from Convertible Debt | USD | 65,000 | 2015-01-01 | 2015-12-31 | 2015 | FY | 10-K | 2016-03-30 | 0001144204-16-091575 |
| us-gaap | ProceedsFromDebtNetOfIssuanceCosts | Proceeds from Debt, Net of Issuance Costs | USD | 8.12M | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-28 | 0001641172-25-001011 |
| us-gaap | ProceedsFromDerivativeInstrumentInvestingActivities | Proceeds from Derivative Instrument, Investing Activities | USD | 2.48M | 2020-01-01 | 2020-12-31 | 2021 | FY | 10-K | 2022-03-30 | 0001493152-22-008184 |
| us-gaap | ProceedsFromIssuanceInitialPublicOffering | Proceeds from Issuance Initial Public Offering | USD | 4.40M | 2026-01-01 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-14 | 0001493152-26-023126 |
| us-gaap | ProceedsFromIssuanceOfCommonStock | Proceeds from Issuance of Common Stock | USD | 1.08M | 2025-01-01 | 2025-03-31 | 2026 | Q1 | 10-Q | 2026-05-14 | 0001493152-26-023126 |
| us-gaap | ProceedsFromIssuanceOfDebt | Proceeds from Issuance of Debt | USD | 782,498 | 2021-01-01 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-15 | 0001493152-21-028733 |
| us-gaap | ProceedsFromIssuanceOfWarrants | Proceeds from Issuance of Warrants | USD | 5.00M | 2026-01-01 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-14 | 0001493152-26-023126 |
| us-gaap | ProceedsFromIssuanceOrSaleOfEquity | Proceeds from Issuance or Sale of Equity | USD | 7.53M | 2024-01-01 | 2024-06-30 | 2024 | Q2 | 10-Q | 2024-08-13 | 0001493152-24-031636 |
| us-gaap | ProceedsFromNotesPayable | Proceeds from Notes Payable | USD | 4.29M | 2020-01-01 | 2020-12-31 | 2021 | FY | 10-K | 2022-03-30 | 0001493152-22-008184 |
| us-gaap | ProceedsFromOtherDebt | Proceeds from Other Debt | USD | 3.85M | 2021-01-01 | 2021-06-30 | 2021 | Q2 | 10-Q | 2021-08-16 | 0001493152-21-019979 |
| us-gaap | ProceedsFromOtherEquity | Proceeds from Other Equity | USD | 54,000 | 2017-01-01 | 2017-03-31 | 2017 | Q1 | 10-Q | 2017-05-15 | 0001493152-17-005361 |
| us-gaap | ProceedsFromRelatedPartyDebt | Proceeds from Related Party Debt | USD | 38,500 | 2018-01-01 | 2018-12-31 | 2019 | FY | 10-K | 2021-03-18 | 0001493152-21-006285 |
| us-gaap | ProceedsFromRepaymentOfLoansToPurchaseCommonStock | Proceeds from Repayment of Loans to Purchase Common Stock | USD | 30,000 | 2016-01-01 | 2016-09-30 | 2016 | Q3 | 10-Q | 2016-11-14 | 0001493152-16-015059 |
| us-gaap | ProceedsFromRepaymentsOfDebt | Proceeds from (Repayments of) Debt | USD | 250,000 | 2021-01-01 | 2021-12-31 | 2022 | FY | 10-K | 2023-03-27 | 0001493152-23-008960 |
| us-gaap | ProceedsFromSaleAndMaturityOfMarketableSecurities | Proceeds from Sale and Maturity of Marketable Securities | USD | 1.04M | 2026-01-01 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-14 | 0001493152-26-023126 |
| us-gaap | ProceedsFromSaleOfPropertyPlantAndEquipment | Proceeds from Sale of Property, Plant, and Equipment | USD | 0 | 2015-01-01 | 2015-12-31 | 2015 | FY | 10-K | 2016-03-30 | 0001144204-16-091575 |
| us-gaap | ProceedsFromStockOptionsExercised | Proceeds from Stock Options Exercised | USD | 42,411 | 2025-01-01 | 2025-03-31 | 2026 | Q1 | 10-Q | 2026-05-14 | 0001493152-26-023126 |
| us-gaap | ProceedsFromWarrantExercises | Proceeds from Warrant Exercises | USD | 1.12M | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001493152-26-012925 |
| us-gaap | ProfessionalFees | Professional Fees | USD | 121,521 | 2022-01-01 | 2022-06-30 | 2022 | Q2 | 10-Q | 2022-08-15 | 0001493152-22-022617 |
| us-gaap | PropertyPlantAndEquipmentAdditions | Property, Plant and Equipment, Additions | USD | 304,055 | 2010-01-01 | 2010-12-31 | 2012 | FY | 10-K | 2013-04-02 | 0001144204-13-019421 |
| us-gaap | PropertyPlantAndEquipmentDisposals | Property, Plant and Equipment, Disposals | USD | 101,423 | 2018-01-01 | 2018-12-31 | 2018 | FY | 10-K | 2019-03-29 | 0001493152-19-004292 |
| us-gaap | PropertyPlantAndEquipmentGross | Property, Plant and Equipment, Gross | USD | 1.59M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001493152-26-012925 | |
| us-gaap | PropertyPlantAndEquipmentNet | Property, Plant and Equipment, Net | USD | 328,810 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-14 | 0001493152-26-023126 | |
| us-gaap | ReorganizationItems | Reorganization Items | USD | -4.08M | 2020-01-01 | 2020-12-31 | 2021 | FY | 10-K | 2022-03-30 | 0001493152-22-008184 |
| us-gaap | RepaymentsOfDebt | Repayments of Debt | USD | -3.11M | 2019-01-01 | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-11-13 | 0001493152-19-017053 |
| us-gaap | RepaymentsOfNotesPayable | Repayments of Notes Payable | USD | 4.89M | 2019-01-01 | 2019-12-31 | 2020 | FY | 10-K | 2021-04-30 | 0001493152-21-010062 |
| us-gaap | RepaymentsOfOtherDebt | Repayments of Other Debt | USD | 5,000 | 2015-01-01 | 2015-12-31 | 2015 | FY | 10-K | 2016-03-30 | 0001144204-16-091575 |
| us-gaap | RepaymentsOfOtherShortTermDebt | Repayments of Other Short-term Debt | USD | -5,000 | 2015-01-01 | 2015-12-31 | 2016 | FY | 10-K | 2017-03-22 | 0001493152-17-002701 |
| us-gaap | RepaymentsOfRelatedPartyDebt | Repayments of Related Party Debt | USD | 38,500 | 2018-01-01 | 2018-12-31 | 2019 | FY | 10-K | 2021-03-18 | 0001493152-21-006285 |
| us-gaap | RepaymentsOfShortTermDebt | Repayments of Short-term Debt | USD | 89,000 | 2016-01-01 | 2016-12-31 | 2016 | FY | 10-K | 2017-03-22 | 0001493152-17-002701 |
| us-gaap | ResearchAndDevelopmentExpense | Research and Development Expense | USD | 1.93M | 2026-01-01 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-14 | 0001493152-26-023126 |
| us-gaap | RestructuringReserveCurrent | Restructuring Reserve, Current | USD | 125,000 | 2013-12-31 | 2013 | FY | 10-K | 2014-04-11 | 0001144204-14-022141 | |
| us-gaap | RetainedEarningsAccumulatedDeficit | Retained Earnings (Accumulated Deficit) | USD | -172.08M | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-14 | 0001493152-26-023126 | |
| us-gaap | RevenueFromContractWithCustomerExcludingAssessedTax | Revenue from Contract with Customer, Excluding Assessed Tax | USD | 23,170 | 2026-01-01 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-14 | 0001493152-26-023126 |
| us-gaap | Revenues | Revenues | USD | 0 | 2024-01-01 | 2024-06-30 | 2024 | Q2 | 10-Q | 2024-08-13 | 0001493152-24-031636 |
| us-gaap | SalariesWagesAndOfficersCompensation | Salary and Wage, Excluding Cost of Good and Service Sold | USD | 565,000 | 2013-01-01 | 2013-12-31 | 2014 | FY | 10-K | 2015-03-31 | 0001144204-15-020255 |
| us-gaap | SaleOfStockNumberOfSharesIssuedInTransaction | Sale of Stock, Number of Shares Issued in Transaction | shares | 12.56M | 2026-01-01 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-14 | 0001493152-26-023126 |
| us-gaap | SaleOfStockPricePerShare | Sale of Stock, Price Per Share | USD/shares | 3.03 | 2023-07-13 | 2024 | FY | 10-K | 2025-03-28 | 0001641172-25-001011 | |
| us-gaap | SecurityDeposit | Security Deposit | USD | 22,100 | 2018-12-31 | 2019 | FY | 10-K | 2021-03-18 | 0001493152-21-006285 | |
| us-gaap | SeveranceCosts1 | Severance Costs | USD | 125,000 | 2015-03-02 | 2015-03-09 | 2014 | FY | 10-K | 2015-03-31 | 0001144204-15-020255 |
| us-gaap | ShareBasedCompensation | Share-based Payment Arrangement, Noncash Expense | USD | 290,215 | 2026-01-01 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-14 | 0001493152-26-023126 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value | USD/shares | 0 | 2014-01-01 | 2014-03-31 | 2014 | Q1 | 10-Q | 2014-05-14 | 0001144204-14-030532 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value | USD/shares | 1.18 | 2016-01-01 | 2016-12-31 | 2017 | FY | 10-K | 2018-04-02 | 0001493152-18-004554 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value | USD/shares | 0 | 2014-03-31 | 2014 | Q1 | 10-Q | 2014-05-14 | 0001144204-14-030532 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value | USD/shares | 0.65 | 2014-01-01 | 2014-03-31 | 2014 | Q1 | 10-Q | 2014-05-14 | 0001144204-14-030532 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate | pure | 0 | 2025-01-01 | 2025-03-31 | 2026 | Q1 | 10-Q | 2026-05-14 | 0001493152-26-023126 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate | pure | 0.954 | 2025-10-08 | 2025 | FY | 10-K | 2026-03-26 | 0001493152-26-012925 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum | pure | 0.991 | 2025-01-01 | 2025-03-31 | 2026 | Q1 | 10-Q | 2026-05-14 | 0001493152-26-023126 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum | pure | 0.987 | 2025-01-01 | 2025-03-31 | 2026 | Q1 | 10-Q | 2026-05-14 | 0001493152-26-023126 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate | pure | 0.037 | 2025-10-08 | 2025 | FY | 10-K | 2026-03-26 | 0001493152-26-012925 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum | pure | 0.044 | 2025-01-01 | 2025-03-31 | 2026 | Q1 | 10-Q | 2026-05-14 | 0001493152-26-023126 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum | pure | 0.043 | 2025-01-01 | 2025-03-31 | 2026 | Q1 | 10-Q | 2026-05-14 | 0001493152-26-023126 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number | shares | 100,000 | 2014-09-30 | 2014 | Q3 | 10-Q | 2014-11-13 | 0001144204-14-067818 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized | Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized | shares | 12.61M | 2022-12-31 | 2022 | FY | 10-K | 2023-03-27 | 0001493152-23-008960 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant | Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant | shares | 1.75M | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-13 | 0001493152-23-040483 | |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value | USD | 392,584 | 2025-03-31 | 2025 | Q1 | 10-Q | 2025-05-14 | 0001641172-25-010299 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number | shares | 4.20M | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-14 | 0001493152-26-023126 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price | USD/shares | 2.67 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-14 | 0001493152-26-023126 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period | shares | 126 | 2021-01-01 | 2021-12-31 | 2022 | FY | 10-K | 2023-03-27 | 0001493152-23-008960 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period | shares | 53,210 | 2026-01-01 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-14 | 0001493152-26-023126 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures | shares | 11,219 | 2014-01-01 | 2014-12-31 | 2014 | FY | 10-K | 2015-03-31 | 0001144204-15-020255 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | shares | 2.20M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001493152-26-012925 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value | USD/shares | 1.88 | 2025-01-01 | 2025-03-31 | 2026 | Q1 | 10-Q | 2026-05-14 | 0001493152-26-023126 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value | USD | 566,088 | 2025-03-31 | 2025 | Q1 | 10-Q | 2025-05-14 | 0001641172-25-010299 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number | shares | 5.21M | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-14 | 0001493152-26-023126 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price | USD/shares | 2.58 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-14 | 0001493152-26-023126 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number | shares | 625 | 2015-06-30 | 2015 | Q2 | 10-Q | 2015-08-14 | 0001144204-15-049960 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price | USD/shares | 4 | 2016-09-30 | 2016 | Q3 | 10-Q | 2016-11-14 | 0001493152-16-015059 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number | shares | 700,000 | 2012-04-02 | 2013 | FY | 10-K | 2014-04-11 | 0001144204-14-022141 | |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares | shares | 1,442 | 2023-01-01 | 2023-12-31 | 2024 | FY | 10-K | 2025-03-28 | 0001641172-25-001011 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum | Share-based Compensation Arrangement by Share-based Payment Award, Percentage of Outstanding Stock Maximum | pure | 0.045 | 2022-01-01 | 2022-06-30 | 2022 | Q2 | 10-Q | 2022-08-15 | 0001493152-22-022617 |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent | Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent | pure | 1.75 | 2014-01-01 | 2014-09-30 | 2014 | Q3 | 10-Q | 2014-11-13 | 0001144204-14-067818 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period | shares | 838,549 | 2022-09-14 | 2022-09-15 | 2022 | FY | 10-K | 2023-03-27 | 0001493152-23-008960 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward | Share-based Compensation Arrangement by Share-based Payment Award, Shares Purchased for Award | shares | 629,017 | 2023-01-01 | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-13 | 0001493152-23-040483 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price | USD/shares | 1.45 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001493152-26-012925 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price | USD/shares | 5.08 | 2021-01-01 | 2021-12-31 | 2022 | FY | 10-K | 2023-03-27 | 0001493152-23-008960 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price | USD/shares | 1.82 | 2026-01-01 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-14 | 0001493152-26-023126 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price | USD/shares | 2.44 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001493152-26-012925 |
| us-gaap | ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions | Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable | shares | 532,045 | 2022-06-30 | 2022 | Q2 | 10-Q | 2022-08-15 | 0001493152-22-022617 | |
| us-gaap | ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions | Share-based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding | shares | 864,609 | 2022-06-30 | 2022 | Q2 | 10-Q | 2022-08-15 | 0001493152-22-022617 | |
| us-gaap | ShareBasedGoodsAndNonemployeeServicesTransactionExpense | Share-based Goods and Nonemployee Services Transaction, Expense (Deprecated 2013-01-31) | USD | 1.59M | 2008-12-30 | 2012-12-31 | 2012 | FY | 10-K | 2013-04-02 | 0001144204-13-019421 |
| us-gaap | ShareBasedGoodsAndNonemployeeServicesTransactionQuantityOfSecuritiesIssued | Share-based Goods and Nonemployee Services Transaction, Quantity of Securities Issued | shares | 31,473 | 2015-01-01 | 2015-12-31 | 2015 | FY | 10-K | 2016-03-30 | 0001144204-16-091575 |
| us-gaap | SharePrice | Share Price | USD/shares | 1 | 2026-03-26 | 2026 | Q1 | 10-Q | 2026-05-14 | 0001493152-26-023126 | |
| us-gaap | ShorttermDebtAverageOutstandingAmount | Short-term Debt, Average Outstanding Amount | USD | 14.70M | 2020-01-01 | 2020-09-30 | 2020 | Q3 | 10-Q | 2021-04-12 | 0001493152-21-008499 |
| us-gaap | StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants | Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants | USD | 5.08M | 2020-11-15 | 2020-11-16 | 2021 | FY | 10-K | 2022-03-30 | 0001493152-22-008184 |
| us-gaap | StockGrantedDuringPeriodValueSharebasedCompensation | Shares Granted, Value, Share-based Payment Arrangement, after Forfeiture | USD | 290,215 | 2026-01-01 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-14 | 0001493152-26-023126 |
| us-gaap | StockholdersEquity | Stockholders' Equity Attributable to Parent | USD | 3.03M | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-14 | 0001493152-26-023126 | |
| us-gaap | StockIssued1 | Stock Issued | USD | 317,376 | 2021-01-01 | 2021-12-31 | 2022 | FY | 10-K | 2023-03-27 | 0001493152-23-008960 |
| us-gaap | StockIssuedDuringPeriodSharesIssuedForCash | Development Stage Entities, Stock Issued, Shares, Issued for Cash (Deprecated 2015-01-31) | shares | 136.56M | 2012-01-01 | 2012-12-31 | 2012 | FY | 10-K | 2013-04-02 | 0001144204-13-019421 |
| us-gaap | StockIssuedDuringPeriodSharesIssuedForServices | Stock Issued During Period, Shares, Issued for Services | shares | 20,000 | 2013-03-21 | 2013-04-10 | 2013 | Q1 | 10-Q | 2013-05-15 | 0001144204-13-029629 |
| us-gaap | StockIssuedDuringPeriodSharesNewIssues | Stock Issued During Period, Shares, New Issues | shares | 678,125 | 2025-10-08 | 2025 | FY | 10-K | 2026-03-26 | 0001493152-26-012925 | |
| us-gaap | StockIssuedDuringPeriodSharesShareBasedCompensation | Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture | shares | 20,000 | 2017-01-01 | 2017-09-30 | 2017 | Q3 | 10-Q | 2017-11-14 | 0001493152-17-013246 |
| us-gaap | StockIssuedDuringPeriodSharesStockOptionsExercised | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period | shares | 29,249 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001493152-26-012925 |
| us-gaap | StockIssuedDuringPeriodValueConversionOfConvertibleSecurities | Stock Issued During Period, Value, Conversion of Convertible Securities | USD | 317,377 | 2021-01-01 | 2021-12-31 | 2022 | FY | 10-K | 2023-03-27 | 0001493152-23-008960 |
| us-gaap | StockIssuedDuringPeriodValueConversionOfUnits | Stock Issued During Period, Value, Conversion of Units | USD | 166,404 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-30 | 0001493152-22-008184 |
| us-gaap | StockIssuedDuringPeriodValueIssuedForServices | Stock Issued During Period, Value, Issued for Services | USD | 7,500 | 2023-01-01 | 2023-12-31 | 2024 | FY | 10-K | 2025-03-28 | 0001641172-25-001011 |
| us-gaap | StockIssuedDuringPeriodValueNewIssues | Stock Issued During Period, Value, New Issues | USD | 4.35M | 2026-01-01 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-14 | 0001493152-26-023126 |
| us-gaap | StockIssuedDuringPeriodValueOther | Stock Issued During Period, Value, Other | USD | 173 | 2026-01-01 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-14 | 0001493152-26-023126 |
| us-gaap | StockIssuedDuringPeriodValueRestrictedStockAwardGross | Stock Issued During Period, Value, Restricted Stock Award, Gross | USD | 985,038 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001493152-26-012925 |
| us-gaap | StockIssuedDuringPeriodValueShareBasedCompensation | Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture | USD | 7,500 | 2023-01-01 | 2023-12-31 | 2024 | FY | 10-K | 2025-03-28 | 0001641172-25-001011 |
| us-gaap | StockIssuedDuringPeriodValueStockOptionsExercised | Stock Issued During Period, Value, Stock Options Exercised | USD | 42,411 | 2025-01-01 | 2025-03-31 | 2026 | Q1 | 10-Q | 2026-05-14 | 0001493152-26-023126 |
| us-gaap | StockIssuedDuringPeriodValueTreasuryStockReissued | Stock Issued During Period, Value, Treasury Stock Reissued | USD | -16,875 | 2016-01-01 | 2016-12-31 | 2017 | FY | 10-K | 2018-04-02 | 0001493152-18-004554 |
| us-gaap | TreasuryStockRetiredCostMethodAmount | Treasury Stock, Retired, Cost Method, Amount | USD | 48,875 | 2016-01-01 | 2016-09-30 | 2016 | Q3 | 10-Q | 2016-11-14 | 0001493152-16-015059 |
| us-gaap | TreasuryStockShares | Treasury Stock, Shares | shares | 0 | 2016-12-31 | 2016 | FY | 10-K | 2017-03-22 | 0001493152-17-002701 | |
| us-gaap | TreasuryStockValue | Treasury Stock, Value | USD | 32,000 | 2015-12-31 | 2016 | FY | 10-K | 2017-03-22 | 0001493152-17-002701 | |
| us-gaap | ValuationAllowanceAmount | Valuation Allowance, Amount (Deprecated 2013-01-31) | USD | 4.74M | 2012-12-31 | 2012 | FY | 10-K | 2013-04-02 | 0001144204-13-019421 | |
| us-gaap | ValuationAllowanceDeferredTaxAssetChangeInAmount | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount | USD | 6.85M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001493152-26-012925 |
| us-gaap | WarrantsAndRightsOutstanding | Warrants and Rights Outstanding | USD | 11,063 | 2015-12-31 | 2016 | FY | 10-K | 2017-03-22 | 0001493152-17-002701 | |
| us-gaap | WeightedAverageNumberOfDilutedSharesOutstanding | Weighted Average Number of Shares Outstanding, Diluted | shares | 17.73M | 2026-01-01 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-14 | 0001493152-26-023126 |
| us-gaap | WeightedAverageNumberOfShareOutstandingBasicAndDiluted | Weighted Average Number of Shares Outstanding, Basic and Diluted | shares | 1.19M | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-30 | 0001493152-22-008184 |
| us-gaap | WeightedAverageNumberOfSharesOutstandingBasic | Weighted Average Number of Shares Outstanding, Basic | shares | 17.73M | 2026-01-01 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-14 | 0001493152-26-023126 |